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During the periparturient period, dairy cows experience major physiological, nutritional, 
metabolic, and immunological events. Methionine, besides been the first limiting amino, is an 
important precursor of antioxidants and methyl donor. Therefore, our objective was to examine 
the effects of enhancing methionine supply on performance, immunometabolic responses, and 
utero-placental metabolism of dairy cows. Sixty multiparous Holstein cows were used in a block 
design and assigned to a control diet or the control plus rumen-protected methionine (MET; 
Mepron, Evonik Nutrition & Care GmbH, Germany). Mepron was fed from −28 to 60 d relative 
to parturition at a rate of 0.09% and 0.10% of DM during the prepartum and postpartum period, 
respectively. That rate ensured that the ratio of lysine to methionine in the metabolizable protein 
was close to 2.8:1. Compared with control, during the fresh period (1-30 days in milk) MET 
increased intake by 1.7 kg/d, milk yield by 4.1 kg/d, fat yield by 0.17 kg/d, and milk protein yield 
by 0.20 kg/d. During the high-producing period (31-60 days in milk), cows fed MET increased 
intake by 1.45 kg/d, milk yield by 4.4 kg/d, fat yield by 0.19 kg/d, and milk protein yield by 0.17 
kg/d, compared with control. MET supplementation reduced plasma fatty acids in the fresh period 
and decreased γ-glutamyl transferase, cholesterol and paraoxonase indicating better liver function. 
Among the inflammation biomarkers measured, MET led to greater albumin (negative acute-phase 
protein) and lower haptoglobin than control cows. Cows supplemented with MET had greater 
plasma concentration of total, β-carotene, tocopherol, and reduced glutathione, whereas reactive 
oxygen metabolites were lower compared with control cows. Compared with control, MET 
enhanced blood neutrophil phagocytosis and oxidative burst. Calves from MET-supplemented 
cows had greater body weight at birth and upregulated mTOR protein expression in the placenta. 
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Regarding placental nutrient transporters, MET-fed cows had 5 upregulated neutral AA trans-
porters (SLC3A2, SLC7A5, SLC38A1, SLC38A2, and SLC38A10). Among the facilitated glucose 
transporters, MET upregulated the expression of SLC2A1, SLC2A3, and SLC2A4. In MET-fed 
cows the long-chain fatty acid transporter SLC27A1 and the betaine transporter SLC6A12 were 
downregulated, while the multivitamin cotransporter SLC5A6 was upregulated. The placentome 
samples were further analyzed considering the offspring’s sex and maternal treatment. Compared 
with placenta from Male CTR, Male MET placenta had greater concentrations of end products of 
the TCA cycle and transsulfuration pathway, and MTR activity. No differences in global DNA 
methylation or mRNA expression of the DNA methyltransferases were observed between Male 
CTR and Male MET. Male MET cows delivered heavier calves than Male CTR; however, this 
difference was not maintained until 9 weeks of age. Female MET placenta compared with Female 
CTR had greater concentrations of metabolites related to one-carbon metabolism and the TCA 
cycle. The de no DNA methyltransferase (DNMT3A and DNMT3B) were upregulated in Female 
MET than Female CTR. Global DNA methylation was lower in Female MET than in Female CTR 
placenta. No difference in calf birth weight was observed between Female CTR and Female MET; 
but, calves from Female MET were heavier at 9 weeks of age. Overall, our results indicated that 
enhancing methionine supply to achieve a lysine:methionine ratio of 2.8:1 during the periparturient 
period increased animal performance during early lactation, mitigated oxidative stress and 
inflammation, and enhanced liver and neutrophil function. Furthermore, MET upregulated utero-
placental transport of nutrients, at least in part, through the mTOR pathway, and altered placenta 
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Protein Nutrition in Dairy Cows 
For many years crude protein (CP) content has been used in formulating diets for 
lactating dairy cows because little was known about the response to dietary protein of 
varying quality. Nowadays, the National Research Council (NRC, 2001), which is the most 
popular software used for ration balancing in the United States, divide the dietary protein 
is divided into two fractions: 1) rumen degradable protein (RDP), which is dietary protein 
metabolized in the rumen, and 2) rumen undegradable protein (RUP), which is dietary 
protein that bypasses the rumen. The RDP can be incorporated into microbial protein or 
degraded into ammonia and absorbed by the rumen epithelial cells. The protein fraction 
that flows with the ruminal digesta to the lower gastrointestinal tract where can be digested 
and absorbed is composed by microbial protein and RUP, and is called metabolizable 
protein. 
The microbial protein represents a mixture of bacteria, protozoa, and fungi and 
usually accounts for more than 50% of the crude protein flowing to the small intestine 
(Schwab and Broderick, 2017). The digestibility of the microbial protein in the small 
intestine is 80% (NRC, 2001). Additionally, the amino acid profile of the microbial protein 
is considered of high quality due to the greatest concentration of essential amino acids. 
There are some differences between the amino acid composition between bacteria and 
protozoa as well. A recent review by Sok and co-authors pointed out that the amino acid 
composition differed between protozoa and bacteria in 5 of the 10 essential amino acids, 
with the largest difference being the lower lysine concentration in bacteria than protozoa 
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(Sok et al., 2017). Therefore, it is important to quantify not only the amount of microbial 
synthesis, but also the chemical composition of the fraction of the microorganisms and 
their contribution to the amino acid supply of the animal. 
The amino acid composition and intestinal digestibility of RUP determine its 
nutritive value to the animal. The NRC (NRC, 2001) predicts intestinal digestibility of RUP 
based on digestion coefficients for the protein in each feed ingredient. The literature 
summary of Santos et al. (Santos et al., 1998) indicated that treating dietary proteins to 
increase RUP did not improve milk or protein yield in lactating cows; these results can be 
attributed to both reduced intestinal digestibility and relatively poor amino acid profile of 
several RUP sources. 
Regarding the utilization of metabolizable protein, the NRC  model assumes that 
the metabolizable protein supply is first used to meet maintenance requirements, which are 
a function of body weight and intake (NRC, 2001). The remainder is used for productive 
functions such as gestation, growth, and milk protein synthesis. When the cow is not 
pregnant or growing and once maintenance requirements are met, metabolizable protein is 
used with 67% efficiency for milk protein synthesis. Arriola Apelo and co-authors 
evaluated the NRC model using 100 treatment means from 25 published studies and 
reported that 82% of the observations had milk yields lower than the predicted 
metabolizable protein-allowable milk (Arriola Apelo et al., 2014). Additionally, the slope 
of residuals regressed on predicted values was −0.34, indicating an over-estimation of the 
efficiency of metabolizable protein for milk protein synthesis. Additionally, the authors 
identified energy and individual amino acids as the nutrients most likely to limit milk 
production.  
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Amino acid balance for optimal metabolizable protein 
It has been known for decades that animals require amino acids for the synthesis of 
tissue, regulatory, protective and secretory proteins and that there are hundreds of these 
proteins that must be synthesized every day (Schwab and Broderick, 2017). Therefore, in 
order to meet animal’s requirements, rather than the amount of total crude protein digested 
in the intestine, the amount and profile of absorbed amino acids is important as well. 
Additionally, special attention is needed for the essential amino acids, which are not 
synthesized by the animal or are synthesized in enough amounts to meet requirements for 
protein synthesis. 
The importance of balancing amino acids has been implied by Schwab to include 
the following: 1) amino acids are the building blocks for protein synthesis, 2) the ideal 
profile of absorbed essential amino acids may be different for maintenance, growth, 
pregnancy and milk production and that as a result, the ideal profile may be different for 
an animal at different stages of its life cycle or at different physiological states (e.g., high 
vs. low milk production), and that 3) providing a more balanced profile of absorbable 
essential amino acids allows meeting amino acid requirements with less dietary protein 
(Schwab, 2012). By selective use of protein supplements and feed sources of the most 
limiting amino acids such as lysine and methionine, amino acid requirements can be met 
with lower concentrations of dietary protein. Balancing diets for amino acid provides the 
opportunity to supply similar or greater amounts of the most limiting amino acid with 
reduced or similar concentrations of RUP; however, because microbial protein provides 
about 50% of the absorbed amino acid requirements of lactating dairy cows, there is less 
opportunity to spare as much as RUP in cows as total dietary protein in pigs or chickens 
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(Schwab, 2012). The NRC  suggests that the required amounts of lysine and methionine in 
the metabolizable protein for optimal milk protein were 7.24 and 2.38%, respectively 
(NRC, 2001). Therefore, in order to amino acids balance diets, a lysine:methionine ratio of 
3:1 has been widely used in dairy cows. 
Production responses to methionine supplementation 
Rumen-protected methionine has been promoted as a product that significantly 
increases the supply of methionine to intestine and consequently milk protein percentage 
(Rulquin and Delaby, 1997). A meta-analysis of 35 studies that investigated the effect of 
rumen-protected methionine added to diets of lactating dairy cattle on dry matter intake, 
milk production, milk protein production, and milk fat yield was performed by Patton 
(Patton, 2010). The author reported that addition of rumen-protected methionine to diets 
increased production of milk protein, both as percentage (0.07%) and yield (27 g/d). Dry 
matter intake and milk fat percentage were slightly decreased, whereas milk production 
was slightly increased. 
Recent research indicates that periparturient cows may benefit the most from 
balancing diets for limiting amino acids. Osorio et al. (2013) supplemented methionine to 
cows around parturition (from –21 to 30 days relative to parturition) with adequate lysine 
in metabolizable protein to fine-tune the lysine:methionine ratio to 2.8:1. No differences in 
prepartal dry matter intake or body condition score were observed. After calving, body 
condition score was lower, whereas dry matter intake was greater for methionine-
supplemented cows. Also, cows supplemented with methionine increased milk yield, milk 
protein percentage, energy-corrected milk, and milk fat yield by 3.4 kg/d, 0.18% units, 3.9 
kg/d, and 0.18 kg/d, respectively. In a following study, Zhou et al. (Zhou et al., 2016b) also 
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evaluated the supplementation of rumen-protected methionine on performance of 
periparturient cows. Methionine-supply led to greater dry matter intake compared with 
control both prepartum (28 days) and postpartum (30 days). Furthermore, cows 
supplemented with methionine had greater yields of milk, milk protein content and yield, 
energy-corrected milk, and fat-corrected milk compared with control. 
The Periparturient Period in Dairy Cows 
The periparturient period describes the time of parturition and those events within 
three weeks of pregnancy prior to and following parturition and it is the most critical stage 
in the life of dairy cows. This phase has achieved new and heightened significance with 
the understanding of biological events around parturition (Mather and Malancon, 1981). 
Notable is the impact of these biological events on economic productivity of the dairy farm 
because of the high incidence of metabolic disorders, and impairment of productive and 
reproductive performance. Another important economic consideration is to reduce calf 
mortality, especially the females, which are needed for heifer replacement. 
Negative Nutrient Balance 
There are major events associated with the shift from a gestational nonlactating 
state to the onset of milk synthesis, e.g., physiological, nutritional, metabolic, and 
immunological (Bell, 1995; Sordillo and Raphael, 2013), that greatly affect the postpartum 
period, and the negative nutrient balance seems to be the most significant one. The gap 
between nutrient supply and demand is consequence of  variations in the diets’ nutrient and 
reduction of intake at the same time that the requirements for milk synthesis peaks, 
requiring comprehensive adaptation and regulation of the metabolism (Drackley, 1999b). 
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The negative energy and metabolizable protein balance leads to mobilization of body 
reserves. The amount of energy that cows assemble from protein during negative energy 
balance is less extensive compared with that mobilized from adipose tissue (Tamminga et 
al., 1997). 
The majority of the mobilized protein is derived from peripheral tissues, especially 
skeletal muscle and, to a smaller degree, skin through suppression of tissue protein 
synthesis, and possibly increased proteolysis (Bell et al., 2000). Mobilization of muscle 
protein by analysis of plasma 3-methylhistidine concentrations and ultrasound 
measurements of longissimus muscle thickness indicate that protein mobilization starts 
before parturition (1-2 weeks) and continues until 3-5 weeks of lactation (Blum et al., 1985; 
Doepel et al., 2002; van der Drift et al., 2012). Komaragiri and Erdman  using an isotope 
technique estimated that cows mobilized ~21 kg of body protein between week -2 and 5 
relative to parturition (Komaragiri and Erdman, 1997). In periods of high metabolic 
demanding, e.g., first week after parturition, it is possible that amino acids are also diverted 
from high rates of synthesis of splenic tissue and export proteins, e.g., albumin (Bell et al., 
2000). The endocrine changes that occurs around parturition, e.g., decrease in plasma levels 
of insulin and insulin-like growth factor-1, together with insulin resistance in peripheral 
tissues, contributes, at least in part, for the mobilization of amino acids (Bell et al., 2000). 
It is clear that protein mobilization occurs during the periparturient period, 
however, the factors that affect the degree to which protein mobilization occurs and its 
particular functions still not well understood. Although ruminants strongly rely on 
gluconeogenesis to meet glucose requirements for maintenance and production 
(Aschenbach et al., 2010), amino acids represent only 11–16% (3–5% alanine; 8–11% 
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other amino acids) of the substrates used for hepatic gluconeogenesis (Reynolds et al., 
2003; Larsen and Kristensen, 2009), and mobilized body protein during early lactation 
seems to be mainly directed to milk protein synthesis instead used for gluconeogenesis 
(Larsen and Kristensen, 2009). Galindo and co-authors observed that the abomasal infusion 
of free amino acid with casein profile did not increased net hepatic release of glucose 
besides the increase demand for lactose secretion, suggesting that cows have metabolic 
priorities for amino acids other than hepatic gluconeogenesis (Galindo et al., 2015). 
Furthermore, protein mobilization might be important for providing anapleurotic 
intermediates for the TCA cycle for complete oxidation of acetyl CoA (Overton and 
Burhans, 2014). Anaplerosis is the act of replacing TCA cycle intermediates that have been 
extracted for biosynthesis (Owen et al., 2002). This process must be balanced, so during 
early lactation where extensive removal of TCA intermediates occurs for gluconeogenesis, 
the amino acid catabolism could ensure an adequate supply of TCA intermediates as an 
approach to keep the cycle running (Bell, 1995). 
The concentration of free fatty acids in the blood and backfat thickness profiles 
showed that fat mobilization occurred from parturition until at least 8 weeks postpartum 
(Tamminga et al., 1997; van Knegsel et al., 2007; van der Drift et al., 2012). During 
negative energy balance, the adipose tissue releases fatty acids from triacylglycerides 
through lipolysis. The lipolysis can be generally divided into two categories: basal and 
demand lipolysis. The demand lipolysis is the one that occurs in response to energy 
requirement and is regulated hormonally (Contreras et al., 2017). Regardless of the type of 
lipolysis, triacylglycerides within the adipocyte lipid droplet are broken down by the action 
of three different lipases: adipose triglyceride lipase, hormone sensitive lipase, and 
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monoglyceride lipase (Contreras et al., 2018). During the periparturient period, compared 
with other stages of lactation, the adipose tissue lipolytic responses are enhanced due to 
hormonal changes associated with parturition and the onset of lactation (Contreras et al., 
2017). The most important hormonal adaptation related to lipolysis is the reduction in 
plasma insulin and increase of insulin resistance in peripheral tissues (Bell, 1995). The 
lipolysis releases free fatty acids into the bloodstream or maybe re-esterified in the 
lipogenic pathway. 
Since the liver uptake free fatty acids from blood in proportion to their 
concentration in plasma (Emery et al., 1992), high concentration of plasma NEFA 
mobilized from adipose tissue precedes a fatty liver condition, which happens when hepatic 
uptake of lipids exceeds the oxidation and secretion of lipids through VLDL (Bobe et al., 
2004). In the hepatocytes, long-chain fatty acids (greater that 14 carbons) are activated by 
acyl-CoA synthetase found in the outer mitochondrial membrane. Short- and medium-
chain fatty acids (lower than 12 carbons) pass through the mitochondrial membrane and 
are activated by acyl-CoA synthetase found within the mitochondria (Drackley, 2000). 
Under conditions of increased fatty acid uptake, the liver often produces large amounts of 
the ketone bodies, acetoacetate and -hydroxybutyrate, in the process known as 
ketogenesis. The two main factors regulating the degree to which fatty acids are oxidized 
by the liver are the supply of fatty acids to the liver via lipolysis and the partitioning within 
hepatocytes between mitochondrial oxidation and microsomal esterification. Ruminants 
have a very low rate of VLDL export compared with rats, despite similar rates of 
esterification of fatty acids to triacylglycerides (Drackley, 2000). It is not well understood, 
but it appears that the rate of synthesis or assembly of VLDLs is more likely to be limiting 
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than is the secretory process per se (Drackley, 2000). 
Excess of triacylglycerol stored in the liver impairs hepatic metabolic function 
(Bobe et al., 2004). Furthermore, the inflammatory response and oxidative stress 
experienced after parturition damage the hepatocytes and shift the synthesis of negative 
acute-phase proteins (e.g., albumin, retinol-binding protein) to positive acute-phase 
proteins (e.g., ceruloplasmin, serum amyloid A, haptoglobin ) (Bionaz et al., 2007; Bertoni 
et al., 2008; Trevisi et al., 2012). 
Inflammation and oxidative stress 
During the periparturient period, adequate liver function and metabolism are 
essential to sustain animal production and health in dairy cows. Although the final trimester 
of pregnancy is characterized by marked fetal growth (NRC, 2001), there is an abrupt 
increase in glucose demand after parturition for lactose synthesis in the mammary gland. 
At 3 weeks prepartum the glucose requirement per day is ~1.2 kg, while at 3 weeks 
postpartum is ~3 kg for a cow producing 36 kg of milk daily (Reynolds et al., 2003; 
Aschenbach et al., 2010). The significance of gluconeogenesis is underscored in dairy 
cattle by the lack of intestinal glucose absorption due to the extensive fermentation of 
carbohydrate in the rumen (Huntington, 1990). In early lactation, more than 90% of whole 
animal glucose requirements are met through gluconeogenesis mainly using propionate as 
substrate (Reynolds et al., 2003). Therefore, optimal liver function supports animal 
performance, at least in part, by the gluconeogenesis process. 
Upon immune activation to challenge by pathogens or tissue damage, mechanisms 
to resolve inflammation are essential to maintain liver function. Failure to clear the stimuli 
or regulate appropriately activated immune mechanisms leads to pathological 
 10 
inflammation and disrupted tissue homeostasis (Robinson et al., 2016). It is well 
established that all the cows during experience some degree of inflammation and oxidative 
stress during the postpartum period (Sordillo and Aitken, 2009; Trevisi et al., 2013). This 
triggers acute phase response, which alters liver function. The liver switches the synthesis 
of negative acute-phase proteins (e.g., albumin) to positive acute-phase proteins (e.g., 
ceruloplasmin, haptoglobin) attempting to reestablish homeostasis (Cray et al., 2009). 
Maternal diet, placenta metabolism and fetal programming 
It has been widely-recognized in recent years that environmental conditions, 
including the maternal diet, play a role in the development and growth of mammals altering 
the phenotype of the offspring (Godfrey and Barker, 2001; Hoffman et al., 2017). This 
process is usually referred as developmental programming and seems to occurs during 
specific time points, e.g., pregnancy and/or in the pre-weaning period after birth, where 
certain plasticity of metabolic regulatory systems is observed (Reynolds and Caton, 2012). 
The placenta seems to have a fundamental function in this process.  
The mTOR pathway and nutrient transport in the placenta 
Changes in placental growth, metabolism and function as well as alterations in 
nutrient transfer and partitioning between mother, placenta and fetus all have important 
effect on fetal adaptations thought to be central to programming (Godfrey, 2002). 
Numerous factors influence transport across the placenta including uteroplacental and 
umbilical blood flows, area available for nutrient exchange, placental metabolism, and 
activity/expression of specific transporter proteins in the placental barrier (Lager and 
Powell, 2012). Oxygen and carbon dioxide, which are highly permeable molecules, are 
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mainly influenced by blood flow (Carter, 2009), while other less permeable substrates uses 
both passive and active transport mechanism. Glucose transfer occurs by facilitated 
diffusion, therefore is highly dependent on maternal-fetal concentration gradients 
(Baumann et al., 2002). Other nutrients, e.g., amino acids and lactate, are transported across 
the placenta mediated by active transport, utilizing energy provided by ion gradients such 
as sodium, chloride, and protons (Lajeunesse and Brunette, 1988; Jansson, 2001). Thus, 
the availability of ions and energy can profoundly affect the transfer of nutrients from the 
maternal to the fetal side. 
Emerging evidence from non-ruminants indicates that the nutrient transporters in 
the placenta actively respond to nutritional signals from the mother through the mechanistic 
target of rapamycin (mTOR). The mTOR has a central function in the ability of cells to 
adapt to its microenvironment regulating both growth and metabolism. mTOR activity is 
regulated by several signals, including growth factor signaling, cellular energy levels via 
AMP-dependent kinase, oxygen levels, and nutrients, particularly amino acids (Goberdhan 
et al., 2016). 
Methionine metabolism and DNA methylation 
Epigenetic marks serve as memory of exposure to the environment, potentially 
affecting fetal and placental programming (Heijmans et al., 2009). These type of 
modifications refer to heritable changes in gene expression that are not mediated by 
alterations in the DNA sequence (Jaenisch and Bird, 2003). Epigenetic mechanisms include 
DNA methylation, histone modification and microRNA (He et al., 2011). 
In non-ruminants, the maternal supplementation of methyl donors affects the 
offspring; the supplementation of betaine (Cai et al., 2014) and folic acid (Liu et al., 2013) 
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to pregnant sows increased protein abundance of gluconeogenic enzymes and of proteins 
that regulate the immune response and energy metabolism in the neonatal piglet. Although 
the impacts of methyl donor supply in dairy cows is still in its infancy, an increase in 
maternal methionine supply during the last 21 days of pregnancy upregulated the 
expression of genes involved in gluconeogenesis and fatty acid oxidation in neonatal calf 
liver, which could benefit the calf’s adaptations to extrauterine life and subsequent growth 
(Jacometo et al., 2016). 
The longer-term carryover effects of maternal supply of methionine and other 
methyl donors on the offspring could be due to the link between epigenetic mechanisms 
and one carbon metabolism. The latter integrates folate and one-carbon cycles and 
generates SAM (Mentch and Locasale, 2016), which impacts DNA methylation and can 
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Despite the prodigious output of research on nutrition and physiology of dairy 
cows, the transition period remains a challenging phase where metabolic disorders continue 
to occur at economically-significant rates (Overton and Waldron, 2004). During the 
transition period, cows experience a number of stressful events including regrouping, 
dietary changes, parturition, and the onset of lactation (Sun et al., 2016). Following 
parturition, cows enter a period of negative energy and protein balance because they cannot 
consume enough DM to support the requirements for lactation (NRC, 2001). Although 
extensive research has been conducted focusing on reducing negative energy balance, less 
emphasis has been put on overcoming protein and indispensable AA imbalances. Previous 
research suggests that increasing RUP during late gestation improves subsequent lactation 
performance (Huyler et al., 1999; Greenfield et al., 2000). The RUP fraction is important 
as a source of essential AA for the mammary gland, and other tissues such as liver and 
skeletal muscle (Osorio et al., 2013). Therefore, an adequate profile and amount of essential 
AA in RUP is crucial for a successful transition into and maintenance of an optimal 
lactation. 
Methionine is typically the first-limiting AA for lactating cows (NRC, 2001). 
Among the various biological functions besides milk protein synthesis for which Met 
availability is important, some of the most relevant to the transition period include 
lipoprotein synthesis in liver, antioxidant synthesis, and synthesis of immune-related 
proteins (e.g. acute-phase proteins) (Osorio et al., 2013; Zhou et al., 2016a). Previous 
studies have observed beneficial effects of rumen-protected Met (RPM) on performance 
(Chen et al., 2011; Osorio et al., 2013) and immunometabolic status (Osorio et al., 2014; 
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Zhou et al., 2016a) of dairy cows during the transition period. However, in those studies 
the effects of RPM on lactation performance were focused only on the immediate 
postpartum period up to 30 DIM. Knowledge of the potential impact of nutritional 
strategies that commence in the last few weeks of the dry period (e.g., the close-up) through 
peak lactation is essential because each additional kg of milk secreted at peak production 
results in approximately 200 kg more milk during the lactation (Roche et al., 2013). 
Therefore, determining the effects of RPM supplementation not only during the peripartal 
period, but also through peak lactation is of particular importance. 
Different sources of RPM might elicit different responses due to inherent 
differences in either coating system or effectiveness of the coating system (Patton, 2010). 
Therefore, our general hypothesis was that feeding ethyl-cellulose RPM starting at 4 wk 
from expected parturition through 60 DIM would improve overall lactation performance 
not only during the peripartal period, but also through peak lactation. The objective of this 
study was to evaluate the impact of feeding ethyl-cellulose RPM on the performance of 
dairy cows during the peripartal and early lactation periods. 
MATERIALS AND METHODS 
Animal Housing and Care 
The Institutional Animal Care and Use Committee at University of Illinois (Urbana; 
protocol # 14270) approved all experimental procedures. The experiment began on October 
25th, 2015 and finished on October 10th, 2016. All cows were housed in a free-stall system 
equipped with gate system (American Calan Inc., Northwood, NH) during the prepartum 
period. After parturition, all cows were housed in tie-stalls. Cows were fed once daily (1300 
h) at 120% of expected intake, and milked three times daily (at 0600, 1400 and 2200 h). 
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Standard reproduction and health herd checks and breeding practices were maintained 
during this study. 
Design and treatment diets 
Sixty multiparous Holstein cows from the University of Illinois Dairy Research 
Farm were used in a randomized, complete block design experiment with 30 cows per 
treatment. Cows were blocked by the expected parturition day, and the blocks were 
balanced by parity, previous 305-d milk yield, and BCS. The BCS used to block cows was 
measured at -30 d before parturition using the scale 1 to 5 (1 = thin, 5 = fat scale in 0.25 
increments). Cows within each block were randomly assigned to one of the two treatments. 
Treatment diets were a basal control diet with no Met supplementation or the basal diet 
plus ethyl-cellulose RPM (Mepron®, Evonik Nutrition & Care GmbH, Germany). Ethyl-
cellulose RPM was supplied from -28 to 60 d relative to parturition at a rate of 0.09% and 
0.10% of the DMI of the previous day during the prepartum and postpartum period. These 
target values were based on recent experiments demonstrating a benefit in terms of 
production performance and health of supplementing rumen-protected Met to achieve a 
Lys:Met ratio close to 2.8:1 during the prepartum and postpartum periods (Osorio et al., 
2013; Zhou et al., 2016b). Mepron® is a commercial rumen-protected source of DL-Met 
which resists ruminal degradation through an ethyl-cellulose film coating. Pellets measure 
1.8 × 3 mm and contain 85% DL-Met. The intestinal digestibility coefficient and rumen 
bypass of Mepron is 90% (Schwab, 1995) and 80% (Overton et al., 1996); therefore, per 
10 g of Mepron, the cows received 6.1 g Met available for absorption. During the far-off 
period (from -45 to -29 d), all cows received the same diet (1.33 Mcal/kg DM and 13.9% 
CP) with no RPM. The basal close-up (from -28 d to parturition), fresh (from 1 to 30 d) 
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and high-production (from 31 to 60 d) diets contained 1.47 Mcal/kg DM and 15.3% CP, 
1.67 Mcal/kg DM and 17.7% CP, and 1.61 Mcal/kg DM and 17.4% CP, respectively. Diets 
were mixed daily in a tumble-mixer and ethyl-cellulose RPM was top-dressed on the TMR. 
The ingredient and nutrient composition of the diets fed are reported in Table 2.1 and 2.2. 
All rations were formulated to meet cow predicted requirements to NRC (NRC, 2001). 
Data and Sample Collection and Analysis 
Dry matter of individual feed ingredients and diets were determined weekly and 
used to adjust the DM of the TMR accordingly. Weekly samples of ingredients and TMR 
were frozen at -20 °C and composited monthly for analysis of CP (AOAC, 2000; method 
990.03), NDF with heat-stable α-amylase and sodium sulfite (Van Soest et al., 1991), ADF 
(Van Soest et al., 1991) and ether extract (AOAC International, 2006; method 2003.05) by 
Cumberland Valley Analytical Services (Hagerstown, MD). Evonik Nutrition & Care 
GmbH analyzed feed ingredients for AA (AOAC, 1995). The values for NEL, RUP, and 
RDP were predicted using the NRC (2001). We used the mean chemical composition of 
feed ingredients throughout the experiment to evaluate prepartal and postpartal diets using 
the NRC (2001) model. Feed offered and refused were recorded daily throughout the entire 
experiment.  
Milk production was recorded daily, and consecutive morning, midday, and 
evening samples were collected once a week, composited in proportion to milk yield and 
stored with preservative at 4 °C before analysis of fat, protein, lactose and MUN by mid-
infrared procedures (Dairy Lab Services, Dubuque, IA). Based on milk sample analysis, 
the 3.5% ECM and FCM were calculated as follows: ECM = [12.82 × fat yield (kg)] + 
[7.13 × protein yield (kg)] + [0.323 × milk yield (kg)], FCM = (0.4324 × kg of milk yield) 
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+ (16.216 × kg of milk fat). Body weight and BCS were recorded weekly throughout the 
entire experiment. Body condition was scored on a 5-point scale, where 1 = thin and 5 = 
fat, as described by Wildman et al. (1982). 
Feed efficiency was calculated by dividing milk yield by DMI, 3.5% ECM by DMI 
and FCM by DMI. The energy balance (EB) was calculated for each cow using equations 
from Hardie et al. (2015). Net energy intake was determined using the average weekly DMI 
multiplied by net energy (NE) density of the diet. Net energy of maintenance was 
calculated as NEM = BW
0.75 × 0.080. Requirements of milk NE were calculated as NEL = 
(0.0929 × fat % + 0.0547 × protein % + 0.0395 × lactose %) × milk yield. Postpartum 
energy balance (Mcal/d) was calculated as NE intake – (NEL+ NEM). 
Blood was sampled from the coccygeal vessel before the AM feeding in 15 cows 
per treatment at d -30, -14, 1, 7, 21, 30, and 60 d relative to calving date. This subset of 
cows was chosen based on absence of clinical disease. Samples were collected into 
evacuated tubes (BD Vacutainer, BD and Co., Franklin Lakes, NJ) containing lithium 
heparin. After blood collection, samples were placed on ice until centrifugation (~40 min). 
Plasma was obtained by centrifugation at 2,000 × g for 30 min at 4 °C. Aliquots of plasma 
were frozen (-80 °C) until further analysis. Glucose (catalog no. 0018250840), urea 
(catalog no. 0018255440), and γ-glutamyl transferase (GGT, catalog no. 0018257640) 
were analyzed using the IL Test purchased from Instrumentation Laboratory Spa (Werfen 
Co., Milan, Italy) in the ILAB 600 clinical auto-analyzer (Instrumentation Laboratory, 
Lexington, MA). Nitric oxide (NOx) and constituents [nitrite (NO2-) and nitrate (NO3-)] 
were determined according methods previously described by Trevisi et al. (Trevisi et al., 
2013). Fatty acids and BHB were measured using kits from Wako Chemicals and Randox 
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Laboratories Ltd., respectively, following the procedures described previously (Bionaz et 
al., 2007; Trevisi et al., 2012). 
Minerals were extracted adding 0.3 mL of trichloracetic acid (10% vol/vol) to 0.3 
mL of plasma, the sample was mixed and centrifuged at 3,500 × g for 10 min at 4°C. A 
volume of 0.3 mL of supernatant was added to 2.7 mL of Millipore water and mixed. 
Calcium, Cl, K, Mg, Na, P and Zn concentrations in final solution were determined with 
an inductively-coupled plasma optical emission spectrometer (ICP-OES 5100, Agilent 
Technologies, Victoria, Australia) fitted with a cyclonic chamber in which samples were 
introduced with SeaSpray nebulizer (Agilent Technologies). Accuracy of results was 
verified using a mineralized solution of SRM 1577b (National Institute of Standards and 
Technology). 
Liver was sampled via puncture biopsy (Dann et al., 2005) from 10 cows per 
treatment. Cows were chosen based on previous 305-d milk yield, BCS, absence of clinical 
disease and enrollment for blood samples. Samples were collected from the same cows 
under local anesthesia at approximately 0800 h on d -21, -10, 1, and 10 relative to 
parturition. Liver was frozen immediately in liquid N and stored (-80 °C) until further 
analysis for concentration of triacylglycerol (TAG) as  described by Zhou et al. (2016b). 
Statistical Analysis 
The production data were analyzed separately for prepartum, fresh (from 1 to 30 d 
postpartum) and high-producing periods (from 31 to 60 d postpartum). All weekly data 
were analyzed using the MIXED procedure of SAS v.9.4 (SAS Institute, Inc. Cary, NC) 
according to the following model with repeated measures: 
Yijkl = μ + bi + Mj + Tk + MTjk + cl (bi) + eijkl, 
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where Yijk = dependent, continuous variable, μ = overall mean, bi = random effect of block 
(i = 1 to 7), Mj = fixed effect of treatment (j = Control vs. ethyl-cellulose RPM), Tk = fixed 
effect of time (d or wk), MTmk = interaction between treatment and time (treat  time), cl 
(bi) = random effect of cow within block, eijk = residual error. The covariates for parity, 
previous 305-d milk yield, and BCS at -30 d relative to parturition were kept in the model 
for all variables when significant (P ≤ 0.15). For the analysis of prepartum DMI, the 
average DMI of individual cows during the far-off period was used as covariate in the 
model, while plasma data at -30 d relative to parturition was included as a covariate for the 
blood biomarker analyses. Unless otherwise specified, first-order autoregressive was the 
covariate structure used for analysis because it resulted in the lowest Bayesian information 
criterion for most of the variables measured. Normality of the residuals was checked with 
normal probability and box plots. Treatment differences within wk were analyzed using 
the SLICE option. Cumulative milk yield and DMI were analyzed using the MIXED 
procedure of SAS using the model described above without time effect. Significance was 
determined at P ≤ 0.05 and tendencies at P ≤ 0.10.  
All cows were in apparent good health at the beginning of the study, and treatment 
groups were not different in terms of previous 305-d milk yield (P = 0.47) or BW (P = 
0.51) and BCS (P = 0.39) at -30 d prepartum. One of the cows in the control had lameness 
with traumatic origin at 37 DIM; thus, the data of the last two wk and the cumulative milk 
yield and cumulative DMI during the high-producing period were excluded from the 






The incidence of disorders is summarized in Table 2.3. Ketosis and retained 
placenta were the most frequent health issues; however, their occurrence was similar 
between treatments. The incidence of retained placenta was higher (67% of total cases) 
during the months of July and August, 2016. 
Diets 
The ingredient composition of the diets is presented in Table 2.1. The nutrient 
composition (Table 1.2) was determined by analyzing each individual feed ingredient for 
its chemical composition and then entering the feed analysis results into the NRC (2001) 
model. 
Close-up DMI 
Cows in the ethyl-cellulose RPM group had greater (P < 0.01) DMI during the 
close-up period (average 1.2 kg/d) and, consequently, had greater (P = 0.01) cumulative 
DMI compared with control (Table 2.4 and Figure 2.1). The DMI in both groups 
progressively decreased from -10 d to parturition. No differences (P > 0.10) between 
treatments were observed for BW and BCS. 
Fresh Period Production Responses 
Ethyl-cellulose RPM supplementation led to greater (P < 0.01) DMI (+1.65 kg/d), 
milk yield (+4.1 kg/d; P = 0.03), fat yield (+0.17 kg/d; P = 0.03), milk protein yield (+0.2 
kg/d; P < 0.01), milk lactose yield (+0.25 kg/d; P = 0.01), 3.5 FCM (+4.3 kg/d; P = 0.01), 
and ECM (+4.4 kg/d; P < 0.01) (Table 2.4; Figure 2.1 and 2.2). A treat × time (P < 0.01) 
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was observed for milk yield due to a greater increase throughout the experiment in ethyl-
cellulose RPM-supplemented cows. In addition, cows in ethyl-cellulose RPM had greater 
cumulative DMI (P < 0.01) and tended (P = 0.07) to have greater cumulative milk yield. 
Although cows in ethyl-cellulose RPM had greater (P = 0.04) milk protein content 
(+0.16% units), no differences (P > 0.10) were observed for milk fat, lactose, and MUN. 
Furthermore, no differences (P > 0.10) were observed for feed efficiency, BW, and BCS. 
As expected, over time both groups of cows experienced increases in DMI, yield of milk 
and milk components, but BW and BCS decreased. 
High Producing Period Responses 
Ethyl-cellulose RPM supplementation led to greater (P = 0.01) DMI (+1.45 kg/d), 
milk yield (+4.4 kg/d; P = 0.04), fat yield (+0.19 kg/d; P = 0.02), milk protein yield (+0.17 
kg/d; P = 0.01), milk lactose yield (+0.30 kg/d; P = 0.01), 3.5% FCM (+4.7 kg/d; P = 0.01) 
and ECM (+4.8 kg/d; P = 0.01) (Table 2.4; Figure 2.1 and 2.2). In addition, cows in ethyl-
cellulose RPM had greater cumulative DMI (P = 0.02) and tended to have greater (P = 
0.08) cumulative milk yield. 
Although cows in ethyl-cellulose RPM had greater (P = 0.04) milk protein content 
(+0.15% units), no differences (P > 0.10) were observed for milk fat, lactose, and MUN. 
Furthermore, no differences (P > 0.10) were observed for feed efficiency, BW, and BCS. 
Energy Balance 
During the fresh period, cows in ethyl-cellulose RPM had NE intakes that were 2.9 
Mcal/d greater and milk energy outputs that were 4 Mcal/d greater compared with controls 
(P < 0.01; Table 2.5). No differences (P > 0.10) in energy partitioned to maintenance and 
energy balance were observed. As lactation progressed, cows increased energy intake and 
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negative energy balance was ameliorated (Figure 1.3). 
In the high producing period, ethyl-cellulose RPM cows had greater energy intake 
(+2.4 Mcal/d; P < 0.01) and milk energy output (+2.8 Mcal/d; P = 0.05). However, no 
differences (P > 0.10) in energy allocated to maintenance and energy balance were 
observed between treatments. 
Biomarkers in Plasma and Liver TAG 
Compared with controls, ethyl-cellulose RPM cows had lower concentrations of 
GGT (P = 0.03) and tended (P = 0.08) to have lower concentrations of fatty acids. No 
differences (P > 0.10) between groups were observed for blood glucose, BHB, urea, NOx, 
NO2, NO3, liver TAG and mineral concentrations (Table 2.6, Figure 2.4). 
DISCUSSION 
Nutrient Composition, and NRC Evaluation of Diets 
The NRC (2001) model assumes that the MP supply is first used to meet 
maintenance requirements, which are a function of BW (endogenous urinary and scurf 
proteins) and DMI (endogenous MP and metabolic fecal protein). The remainder is used 
for productive functions such as gestation, growth, and milk protein synthesis (Arriola 
Apelo et al., 2014). Corroborating results from previous studies using different sources of 
RPM, the MP balance was positive prepartum and negative postpartum regardless of 
treatment (Osorio et al., 2013). Considering that there was no difference in cow BW 
prepartum, it was expected that RPM-supplemented cows had a more positive MP balance 
prepartum. This positive MP balance during the prepartum period was not only from the 
RUP, but also from positive RDP values in both treatments. 
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Despite the greater estimated supply of MP in ethyl-cellulose RPM-supplemented 
cows, according to NRC (2001), a more negative MP balance was observed postpartum in 
this group. This was likely due to the greater MP requirement to sustain increases in milk 
and milk protein yield with ethyl-cellulose RPM supplementation. During the postpartum 
the estimated increase of MP requirement for cows fed ethyl-cellulose RPM was 257 and 
122 g/d for fresh and high producing periods, respectively. The more negative protein 
balance in ethyl-cellulose RPM cows might have resulted in greater protein mobilization 
from muscle to match requirements. However, we did not observe differences in BW 
between groups throughout the study. 
The desired duodenal supply of Lys and Met to maximize milk protein content and 
yield during established lactation has been suggested to be 7.2% and 2.4% of MP, 
respectively (NRC, 2001). In the present study, Lys was roughly constant at 6.5% of MP, 
while ethyl-cellulose RPM supplementation increased on average Met from 1.70 to 2.25% 
of MP. Also, we estimated that ethyl-cellulose RPM supplementation decreased duodenal 
Lys:Met ratio from 3.78, 3.71, and 3.71 in the prepartum, fresh, and high-production 
periods, respectively, to 2.81:1, 2.88:1, and 2.82:1. 
Dry Matter Intake 
Previous studies with RPM supplementation have resulted in inconsistent responses 
in DMI (Ordway et al., 2009; Chen et al., 2011; Osorio et al., 2013). For instance, Patton 
(2010) compiled data from 35 studies where RPM was fed and reported a high 
heterogeneity in the DMI response, which indicated that other factors such as differences 
in level of RPM supplementation, length of feeding period, and/or stage of lactation likely 
confounded the results. In our study, ethyl-cellulose RPM supplementation increased DMI 
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not only in the prepartum and immediate postpartum period as previously observed (i.e.; 
Osorio et al., 2013; Zhou et al., 2016b), but also when fed in the high producing period up 
to 60 DIM. 
The consistently greater DMI in RPM-fed cows during the transition period has 
been associated with better immunometabolic status, a reduction in inflammation and 
oxidative stress status and better liver function (Osorio et al., 2014; Zhou et al., 2016a). 
The lower concentration of the enzyme GGT could be considered one indicator (Bertoni et 
al., 2008) of better liver function in ethyl-cellulose RPM-fed cows. Previously, Zhou et al. 
(2016ab) demonstrated that cows with better liver function had greater DMI. Hence, the 
positive effect of ethyl-cellulose RPM on liver function can explain, at least in part, the 
greater DMI. 
In the context of feed intake regulation, the hepatic energy status has been proposed 
as a major regulator in dairy cows, i.e., as hepatic oxidative fuel supply increases the brain 
is signaled via the vagal afferent nerve to reduce intake (Allen et al., 2009). Although it is 
thought that propionate and fatty acids are primary fuels that cause hypophagia in 
ruminants (Allen et al., 2009), more recent data suggest that fatty acids are the most 
quantitatively important hepatic oxidative substrates during the peripartal period 
(McCarthy et al., 2015a; McCarthy et al., 2015b). Thus, the tendency for greater 
concentration of fatty acids in early-lactation in the control group could have been 
associated with an increase in acetyl CoA oxidized within the tricarboxylic acid cycle 
(Drackley et al., 2001), and may have been one of the causes for the lower DMI compared 
with ethyl-cellulose RPM-fed cows. 
Milk Production and Milk Composition 
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Overall, RPM supplementation has resulted in inconsistent responses in milk yield 
(Ordway et al., 2009; Chen et al., 2011; Osorio et al., 2013). Previous studies did not detect 
increases in milk yield when RPM or Met analog was fed (Piepenbrink et al., 2004; Socha 
et al., 2005; Ordway et al., 2009; Preynat et al., 2009) while others observed positive 
responses when supplied until 30 DIM (Overton et al., 1996; Piepenbrink et al., 2004; 
Osorio et al., 2013; Sun et al., 2016; Zhou et al., 2016b). To our knowledge, our study is 
the first to demonstrate that RPM supplementation elicits a sustained increase in milk 
production from the immediate postpartum period (+4.1 kg/d until 30 DIM) through the 
peak of lactation (+4.4 kg/d from 30 to 60 DIM). This increase in milk yield is likely related 
to the greater DMI in ethyl-cellulose RPM-supplemented cows. 
The increase in ECM from 4.3 kg/d to 4.7 kg/d with ethyl-cellulose RPM 
supplementation between the fresh and high-producing periods was associated with 
positive effects on the yield of milk components, i.e., milk protein content and yield, which 
underscores that milk protein early postpartum is directly affected by the adequacy of AA 
in the MP (NRC, 2001). From a meta-analysis, Patton (2010) observed that cows that were 
Met-deficient responded to RPM supplementation with greater milk protein and milk fat 
yield. The milk protein response in the present study was similar to previous results from 
our group (Osorio et al., 2013; Zhou et al., 2016b). It is also noteworthy that the milk 
protein yield responses detected during the fresh period in the present study and in previous 
studies from our laboratory (Osorio et al., 2013; Zhou et al., 2016b) were greater (from 120 
to 190 g/d) than the values reported by Patton (2010). 
Similar to our current findings, a previous study using RPM (Osorio et al., 2013) 
detected an increase in milk fat yield. An unexplored area of essential AA metabolism in 
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dairy cows is the potential effect of these nutrients on mRNA expression of lipogenic target 
genes. For instance, Li et al. (2016) using an in vitro model observed that an “optimal” AA 
balance stimulated the mRNA expression of enzymes related to de novo FA synthesis 
(ACACA, FASN) and desaturation (SCD), triacylglycerol synthesis (LPIN1), and 
transcription regulation of lipid synthesis (SREBF1, INSIG1) in bovine mammary cells. 
The effects of Met supplementation on regulation of mammary fatty acid synthesis 
deserves further investigation. 
In our study, supplementation of ethyl-cellulose RPM increased energy intake but 
did not reduce the negative energy balance compared with controls. This result was 
expected since we observed greater milk energy output in ethyl-cellulose RPM-
supplemented cows due to the increase in milk yield and milk protein yield. A previous 
study (Gowanlock et al., 2015) reported a similar magnitude of negative energy balance 
when supplementing ethyl-cellulose RPM up to 30 DIM. In addition, the tendency for 
lower fatty acid and the lower GGT concentrations in ethyl-cellulose RPM-supplemented 
cows is indicative of an improvement in metabolic status, which has been associated with 
an increase in NE efficiency due in part to a decrease in energy demands by the immune 
system (Trevisi et al., 2010; Kvidera et al., 2016). 
Metabolism Biomarkers and Liver TAG 
Epidemiological data have established a positive association between increased 
blood concentrations of fatty acids and BHB, and negative health and production outcomes 
at both the individual cow and herd level (Duffield et al., 2009; Ospina et al., 2013). In our 
study, although we did not observe differences between treatments for BHB concentration, 
ethyl-cellulose RPM supplementation tended to reduce fatty acid concentration. A recent 
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study also reported lower fatty acid concentrations from 1 to 21 DIM in cows supplemented 
with ethyl-cellulose RPM (Sun et al., 2016). Therefore, it is reasonable to speculate that 
ethyl-cellulose RPM-supplemented cows in the present study were able to metabolize 
circulating fatty acids more “efficiently” either in the liver or through uptake by the 
mammary gland or other peripheral tissues. 
CONCLUSIONS 
Results indicate that feeding ethyl-cellulose RPM to achieve a ratio of 2.8:1 Lys to 
Met (0.09-0.10% of diet DM) during the periparturient period enhanced lactation 
performance from 1 to 60 DIM. The greater milk production was, at least in part, driven 
by the greater voluntary DMI and better liver function. To our knowledge, this is the first 
study reporting that ethyl-cellulose RPM supplementation starting from 4 wk prepartum 
improves performance not only in the immediate postpartum period but also through the 
peak of lactation.  
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Table 2.1 Ingredient and nutrient composition of far-off (from -45 to -29 d), close-up (from -28 to 
parturition), fresh (from 1 to 30 DIM) and high-producing (from 31 to 60 DIM) diets. 
  Diet 
Ingredient, % of DM Far-off Close-up Fresh High producing 
Alfalfa haylage - 6.55 7.81 10.8 
Corn silage 34.7 26.6 31.0 31.9 
Wheat straw 33.7 26.5 3.25 - 
Corn grain, ground, dry - 12.6 22.21 20.7 
Cottonseed - - 2.17 1.83 
Molasses, beet sugar - 4.03 5.50 4.51 
Soybean hulls 15.7 3.46 4.25 9.96 
Soybean meal, 48% CP 12.0 7.83 10.1 7.98 
Expeller soybean meal1 - 5.80 5.16 5.17 
Protein supplement2 - 0.78 1.81 1.58 
Urea 0.46 0.59 0.39 0.40 
Soychlor3 - 1.23 - - 
Saturated fat supplement4 - - 2.25 2.14 
Limestone - - 1.41 0.96 
Salt 0.40 - 0.02 0.04 
Dicalcium phosphate 0.50 0.52 1.17 0.92 
Magnesium oxide - - 0.08 0.04 
Magnesium sulfate 1.90 2.08 0.02 - 
Sodium Bicarbonate - - 0.84 0.59 
Mineral vitamin mix5 0.40 0.17 0.17 0.20 
Vitamin A6 - 0.03 0.02 0.02 
Vitamin D7 - 0.03 - - 
Vitamin E8 0.40 0.60 - - 
Biotin9 - 0.70 0.42 0.32 
Momensin10 0.01 - - - 
Ethyl-cellulose RPM11 - 0.09 0.10 0.10 
1SoyPlus, West Central Soy, Ralston, IA. 
2ProVAAl AADvantage, Perdue AgriBusiness, Salisbury, MD. 
3West Central Soy, Ralston, IA. 
4Energy Booster 100, Milk Specialties Global, Eden Prairie, MN. 
5Contained a minimum of 5% Mg, 10% S, 7.5% K, 2.0% Fe, 3.0% Zn, 3.0% Mn, 5,000 mg of Cu/kg, 250 mg of I/kg, 40 
mg of Co/kg, 150 mg of Se/kg, 2,200 kIU of vitamin A/kg, 660 kIU of vitamin D3/kg, and 7,700 IU of vitamin E/kg. 
6Contained 30,000 kIU/kg. 
7Contained 5,000 k IU/kg. 
8Contained 44,000 kIU/kg. 
9ADM Animal Nutrition, Quincy, IL. 
10Rumensin, Elanco Animal Health, Greenfield, IN. 
11Ethyl-cellulose rumen-protected methionine, Evonik Nutrition & Care GmbH, Hanau-Wolfgang, Germany. Only 
added in the treatment group.
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Table 2.2 Nutrient composition and diet evaluation using the NRC (2001) of prepartal and postpartal diets fed to multiparous Holstein cows 
supplemented with ethyl-cellulose rumen-protected methionine (RPM). 
 
Far-off 













Chemical composition, % DM1        
  CP 13.9 ± 0.25 15.6 ± 0.32 15.7 ± 0.32 17.7 ± 0.36 17.7 ± 0.36 17.4± 0.36 17.6 ± 0.36 
  NDF 54.5 ± 0.75 40.8 ± 0.68 40.7 ± 0.68 29.2 ± 0.59 29.3 ± 0.59 31.4 ± 0.62 31.3 ± 0.62 
  ADF 36.9 ± 0.65 27.5 ± 0.50 27.4 ± 0.50 19.5 ± 0.38 19.6 ± 0.38 21.5 ± 0.48 21.4 ± 0.48 
  NFC 24.7 ± 0.72 34.9 ± 0.81 34.9 ± 0.81 41.4 ± 0.55 41.4 ± 0.55 40.7 ± 0.54 40.9 ± 0.54 
  Ether extract 1.81 ± 0.04 2.32 ± 0.05 2.33 ± 0.05 5.12 ± 0.14 5.11 ± 0.14 5.13 ± 0.14 5.15 ± 0.14 
Calculated with NRC (2001)2        
  NEL, Mcal/kg of DM 1.33 1.47 1.47 1.67 1.67 1.60 1.60 
  NEL allowable milk, kg/d - - - 32.3 34.8 42.8 45.3 
  MP allowable milk, kg/d - - - 38.8 40.8 49.4 51.7 
  RDP, % of DM 8.8 9.4 9.4 10.2 10.2 9.9 10 
  RUP, % of DM 5.1 6.2 6.3 7.4 7.5 7.4 7.6 
  RDP balance, g/d 8 10 7 11 9 3 7 
  RUP balance, g/d 537 673 794 -138 -191 -28 -128 
  MP balance, g/d 421 555 664 -118 -160 -23 -66 
  Lys, % of MP 6.74 6.54 6.51 6.40 6.38 6.33 6.29 
  MP-Lys, g 82 89 89 155 156 194 195 
  Met, % of MP 1.77 1.73 2.30 1.70 2.24 1.68 2.22 
  MP-Met, g 21 24 32 41 56 52 68 
  Lys:Met 3.81:1 3.71:1 2.81:1 3.78:1 2.88:1 3.78:1 2.82:1 
1Mean ± standard deviation. 
2The NRC (2001) evaluation of diets was based on final averaged pre- and postpartum DMI, production data, and feed analysis.   
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Table 2.3 Health incidents in multiparous Holstein cows fed control or ethyl-cellulose 
rumen-protected methionine (RPM) during the close-up period (from -28 d to parturition), 




During close-up period   
  Lameness 1 0 
During postpartum 1-30 d   
  Ketosis1 8 7 
  Lameness 1 1 
  Mastitis 1 2 
  Milk fever 1 0 
  Retained placenta2 7 8 
  Displaced abomasum 2 1 
During postpartum 31-60 d   
  Lameness (traumatic origin) 0 1 
  Mastitis 1 0 
1Defined as cows having large ketone concentration (> 80 mg/dL) in urine. Tested once a day. 
2Defined as fetal membranes retained ≥ 24 h after calving. 
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Table 2.4 Effects of ethyl-cellulose rumen-protected methionine (RPM) supplementation 
to multiparous Holstein dairy cows during the close-up period (from -28 d to parturition), 









Treatment1 Time Treat × Time 
Close up 
DMI, kg/d 14.6 15.8 0.13 <0.01 <0.01 0.58 
Cumulative DMI, kg 342 382 10.5 0.01 NA2 NA 
BW, kg 789 784 15.6 0.60 0.68 0.98 
BCS 3.76 3.74 0.06 0.70 <0.01 0.58 
Fresh period       
 DMI, kg/d 16.1 17.7 0.35 <0.01 <0.01 0.71 
 Cumulative DMI, kg 476 520 10.40 <0.01 NA NA 
 Yield, kg/d       
   Milk 37.1 41.2 1.48 0.03 <0.01 <0.01 
   Fat 1.59 1.76 0.07 0.03 <0.01 0.63 
   Protein 1.22 1.41 0.48 <0.01 0.08 0.95 
   Lactose 1.86 2.11 0.07 <0.01 0.01 0.29 
   3.5% FCM 37.3 41.6 1.70 0.01 <0.01 0.68 
 Milk composition, %       
   Fat 4.10 4.07 0.11 0.58 <0.01 0.45 
   Protein 3.19 3.35 0.06 0.04 <0.01 0.68 
   Lactose 4.73 4.75 0.03 0.48 <0.01 0.93 
   MUN, mg/dL 13.1 13.3 0.30 0.41 0.70 0.74 
 BW, kg 705 700 16.10 0.67 0.02 0.98 
 BCS 3.16 3.17 0.06 0.65 <0.01 0.13 
High producing period 
 DMI, kg/d 20.6 22.1 0.40 0.01 0.05 0.23 
 Cumulative DMI, kg 613 655 12.8 0.02 NA NA 
 Yield, kg/d       
   Milk 45.8 50.2 1.70 0.04 0.65 0.98 
   Fat 1.60 1.79 0.07 0.02 <0.01 0.86 
   Protein 1.23 1.40 0.05 0.01 0.21 0.83 
   Lactose 2.20 2.50 0.09 0.01 0.44 0.87 
   3.5% FCM 45.9 50.6 1.84 0.01 0.11 0.88 
 Cumulative milk yield, kg 1371 1488 54.50 0.08 NA NA 
 Milk composition, %       
   Fat 3.62 3.57 0.09 0.70 <0.01 0.93 
   Protein 2.72 2.87 0.05 0.04 <0.01 0.18 
   Lactose 4.86 4.89 0.03 0.15 <0.01 0.99 
   MUN, mg/dL 15.5 15.6 0.23 0.86 0.77 0.82 
 BW, kg 668 664 16.1 0.67 0.91 0.99 
 BCS 2.95 2.94 0.06 0.24 0.01 0.98 
1 Ethyl-cellulose rumen-protected methionine effect.  
2NA = not applicable. 
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Table 2.5 Effects of ethyl-cellulose rumen-protected methionine (RPM) supplementation to 
multiparous Holstein dairy cows during the close-up period (from -28 d to parturition), fresh (from 1 
to 30 DIM) and high-producing (from 31 to 60 DIM) periods on net energy (NE) intake, milk energy 








Treatment1 Time Treat × Time 
Fresh period             
  NE intake 26.7 29.6 0.48 <0.01 <0.01 0.93 
  NE lactation 29.2 33.2 1.05 <0.01 <0.01 0.95 
  NE maintenance 10.3 10.5 0.24 0.57 <0.01 0.73 
  Energy balance -13.5 -14.7 0.91 0.35 <0.01 0.92 
High-producing        
  NE intake 32.9 35.3 0.36 <0.01 0.28 0.43 
  NE lactation 31.2 34.0 1.12 0.05 0.43 0.99 
  NE maintenance 10.3 10.5 0.24 0.57 <0.01 0.73 
  Energy balance -6.41 -7.31 1.13 0.60 0.06 0.89 
1 Ethyl-cellulose rumen-protected methionine effect.  
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Table 2.6 Effects of ethyl-cellulose rumen-protected methionine (RPM) supplementation to multiparous 
Holstein dairy cows during the close-up period (from -28 d to parturition), fresh (from 1 to 30 DIM) and 
high-producing (from 31 to 60 DIM) periods on blood biomarkers and liver triacylglycerol (TAG) 
concentrations. 





Treatment1 Time Treat × Time 
Blood       
  BHB, mmol/L 1.10 0.97 0.12 0.75 0.05 0.72 
  Glucose, mmol/L 4.13 4.24 0.08 0.21 <0.01 0.45 
  Fatty acids, mmol/L 0.71 0.63 0.05 0.08 <0.01 0.64 
  Urea, mmol/L 5.73 5.89 0.33 0.28 <0.01 0.41 
  γ-glutamyl transferase, U/L 18.2 11.5 3.80 0.03 <0.01 0.38 
  Nitric oxide, µmol/L 24.3 24.0 0.14 0.60 <0.01 0.52 
  Nitrite, µmol/L 6.34 5.70 0.52 0.16 <0.01 0.62 
  Nitrate, µmol/L 18.1 18.6 0.11 0.38 <0.01 0.29 
  Calcium, mmol/L 2.44 2.48 0.02 0.19 <0.01 0.81 
  Chlorine, mmol/L 105 104 0.30 0.31 <0.01 0.72 
  Potassium, mmol/L 4.71 4.70 0.06 0.87 0.42 0.88 
  Magnesium, mmol/L 0.94 0.96 0.02 0.36 <0.01 0.90 
  Sodium, mmol/L 144 143 0.49 0.26 <0.01 0.72 
  Phosphorous, mmol/L 2.14 2.15 0.04 0.96 <0.01 0.39 
  Zinc, mmol/L 12.5 12.2 0.22 0.30 <0.01 0.56 
Liver       
  TAG, mg/g of wet wt 31.1 29.3 2.71 0.38 <0.01 0.35 
























Figure 2.1 Effects of ethyl-cellulose rumen-protected methionine (RPM) supplementation to 
multiparous Holstein cows from -28 through 60 DIM on prepartum DMI (last 28 d of pregnancy), 
postpartum DMI (from 1 to 60 DIM), milk yield, and energy corrected milk. 
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Figure 2.2 Effects of ethyl-cellulose rumen-protected methionine (RPM) supplementation to 
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Figure 2.3 Effects of ethyl-cellulose rumen-protected methionine (RPM) supplementation to 
multiparous Holstein cows from -28 through 60 DIM on energy intake, milk energy and energy 
balance. 
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Figure 2.4 Effects of ethyl-cellulose rumen-protected methionine (RPM) supplementation to 
multiparous Holstein cows from -28 through 60 DIM on blood glucose, BHB, fatty acids, urea and 
γ-glutamyl transferase (GGT), and liver TAG (triacylglycerol) (from -14 to 21 DIM). Data for d 
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The periparturient period is the most critical phase in the productive life of high-
producing dairy cows, and is characterized by the highest incidence and severity of both 
metabolic and infectious diseases (Bertoni et al., 2008; Trevisi et al., 2012; Sordillo, 2016). 
The inflammatory response can be activated by infection or injury as well as tissue stress 
and malfunction in the absence of infection or evident tissue damage (Chovatiya and 
Medzhitov, 2014; Trevisi et al., 2016). The classic initiators of inflammation, infection and 
tissue injury trigger the recruitment of leukocytes to the damaged or contaminated tissue, 
and immune cell function is fundamental for the efficiency and duration of the 
inflammatory process (Medzhitov, 2008). In cases of tissue stress or malfunction, the 
inflammatory response is mainly dependent on tissue-resident macrophages and based on 
human disease models it is responsible for chronic inflammatory conditions (Medzhitov, 
2008). Furthermore, the inflammatory process triggers the acute phase response, which 
alters liver function. The liver switches the synthesis of negative acute-phase proteins (e.g., 
albumin) to positive acute-phase proteins (e.g., ceruloplasmin, haptoglobin) attempting to 
reestablish homeostasis (Cray et al., 2009). 
Most dairy cows in early lactation experience a prolonged imbalance between 
production of free radicals and their elimination by antioxidants (Sordillo and Aitken, 
2009), often causing cellular damage followed by a chronic inflammatory response. 
Oxidative stress around calving also can be a consequence of an infection-induced 
inflammatory response (Trevisi et al., 2016). Thus, the inflammatory events that afflict 
cows during early lactation are due to parturition per se, associated with psychological 
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stressful conditions, and the metabolic overload of the liver to meet the nutrient 
requirements for maintenance and milk synthesis (Trevisi et al., 2016). 
It is well-established that transition cows experience negative energy and protein 
balance (Drackley, 1999a), and that nutrition plays a critical role in supporting the immune 
system (Bertoni et al., 2015; Sordillo, 2016). Methionine is the first limiting AA in dairy 
cows (NRC, 2001) and recent data underscored its immunometabolic potential (Osorio et 
al., 2014b; Sun et al., 2016; Zhou et al., 2016a). In the liver, methionine can be metabolized 
to S-adenosylmethionine, a fundamental methyl donor (Martinov et al., 2010), as well as 
phosphatidylcholine, which is a main constituent of very low density lipoproteins. 
Furthermore, methionine metabolism can generate intracellular antioxidants such as 
glutathione (GSH) and taurine (Brosnan and Brosnan, 2006). Therefore, our general 
hypothesis was that feeding ethyl-cellulose rumen-protected methionine (RPM) starting at 
d -28 from expected parturition through 60 DIM would alleviate the inflammatory and 
oxidative stress status and enhance liver function and leukocyte function in the cow. 
MATERIALS AND METHODS 
Animal Housing and Care 
The Institutional Animal Care and Use Committee at University of Illinois (Urbana; 
protocol # 14270) approved all experimental procedures. All cows were housed in a free-
stall system equipped with the Calan gate system (American Calan Inc., Northwood, NH) 
during the prepartum period. After parturition, all cows were housed in tie-stalls. Cows 
were fed once daily (1300 h) at 120% of expected intake, and milked three times daily 
(0600, 1400 and 2200 h). 
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Design and Treatments 
Additional details of the experimental design have been described previously 
(Batistel et al., 2017b). Briefly, sixty multiparous Holstein cows from the University of 
Illinois Dairy Research Farm were used in a randomized, complete, unbalanced block 
design experiment with 30 cows per treatment. Cows were blocked by the expected 
parturition day, and the blocks were balanced by parity, previous 305-d milk yield, and 
BCS. The BCS used to block cows was measured at -30 d before parturition using the scale 
1 to 5 (1 = thin, 5 = fat, scale in 0.25 increments). Cows within each block were randomly 
assigned to one of the two treatments. Treatment diets were a control diet without Met 
supplementation or the control diet plus ethyl-cellulose RPM (Mepron®, Evonik Nutrition 
& Care GmbH, Germany). Ethyl-cellulose RPM was supplied from -28 to 60 d relative to 
parturition at a rate of 0.09% and 0.10% of the DMI of the previous day during the 
prepartum and postpartum period. These target values were based on recent experiments 
demonstrating a benefit in terms of production performance and health of supplementing 
rumen-protected Met to achieve a Lys:Met ratio close to 2.8:1 during the prepartum and 
postpartum periods (Osorio et al., 2013; Zhou et al., 2016b). Mepron® is a commercial 
rumen-protected source of DL-Met which resists ruminal degradation through an ethyl-
cellulose film coating. Pellets measure 1.8 × 3 mm and contain 85% DL-Met. The intestinal 
digestibility coefficient and rumen bypass of Mepron is 90% (Schwab, 1995) and 80% 
(Overton et al., 1996); therefore, per 10 g of Mepron, the cows received 6.1 g Met available 
for absorption. During the far-off period (from -45 to -29 d), all cows received the same 
diet (1.33 Mcal/kg DM and 13.9% CP) with no RPM. The basal close-up (from -28 d to 
parturition), fresh (from 1 to 30 d) and high-production (from 31 to 60 d) diets contained 
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1.47 Mcal/kg DM and 15.3% CP, 1.67 Mcal/kg DM and 17.7% CP, and 1.61 Mcal/kg DM 
and 17.4% CP, respectively. The ingredient and nutrient composition of the diets fed are 
reported in Table 3.1 and 3.2. All rations were formulated to meet cow predicted 
requirements to NRC (NRC, 2001).  
Blood and Liver Sample Collection and Biomarker Analysis 
Blood was sampled from the coccygeal vessel before the feeding in 15 cows per 
treatment at d -30, -14, 1, 7, 21, 30, and 60 d relative to calving date. This subset of cows 
was chosen based on absence of clinical disease and enrollment for liver biopsy. Liver 
biopsy cows were chosen based on previous 305-d milk yield, BCS and absence of clinical 
disease. Samples were collected into evacuated tubes (BD Vacutainer, BD and Co., 
Franklin Lakes, NJ) containing lithium heparin. After blood collection, samples were 
placed on ice until centrifugation (~40 min) or the neutrophil function assay. Plasma was 
obtained by centrifugation at 2,000 × g for 30 min at 4 °C. Aliquots of plasma were frozen 
(-80 °C) until further analysis. 
Liver was sampled via puncture biopsy (Dann et al., 2005) from 10 cows per 
treatment. Samples were collected from the same cows under local anesthesia at 
approximately 0800 h on d -21, -10, 1, and 10 relative to parturition. Liver was frozen 
immediately in liquid N and stored (-80 °C) until further analysis. 
Plasma samples were analyzed for albumin (catalog no. 0018250040), aspartate 
aminotransferase (catalog no. 0018257540), bilirubin (catalog no. 0018254640), and 
cholesterol (catalog no. 0018250540) using kits purchased from Instrumentation 
Laboratory Spa (Werfen Co., Milan, Italy) using the clinical auto-analyzer (ILAB 650, 
Instrumentation Laboratory).  Haptoglobin, ceruloplasmin and paraoxonase were 
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determined by adapting the methods of  (Owen et al., 1960) and (Skinner et al., 1991), 
(Sunderman and Nomoto, 1970), and (Ferre et al., 2002), respectively, to the ILAB 650 
conditions. Reactive oxygen metabolites (ROM) were analyzed with the d-ROMs-test 
(cod. MC002) purchased from Diacron (Grosseto, Italy). Total antioxidant capacity was 
assessed as ferric reducing antioxidant power (FRAP) using the colorimetric method of 
(Benzie and Strain, 1996). Myeloperoxidase was determined as previously described 
(Bionaz et al., 2007), via colorimetry based on the reaction of MPO contained in the plasma 
sample with hydrogen peroxide, which forms H2O and O
−; the O− dianisidine 
dihydrochloride, and electron donor, reacts with the O−, releasing H2O and a colored 
compound. Plasma retinol and tocopherol were extracted with hexane and analyzed by 
reverse-phase HPL Cusing Spherisorb ODS-2, 3 µm, in a 150×4.6 mm column (Alltech, 
Deerfield, IL); a UV detector set at 325 nm (for retinol) or 290 nm (for tocopherol); and 
80:20 methanol:tetrahydrofurane as the mobile phase. Bovine interleukin-1β (IL-1β; Cat. 
No. ESS0027; Thermo Scientific, Rockford, IL) and interleukin-6 (IL-6; Cat. No. 
ESS0029; Thermo Scientific) plasma concentration were determined using commercial 
kits.  
The simultaneous phagocytosis capacity and oxidative burst activity of peripheral 
monocytes and neutrophils was determined upon challenge with enteropathogenic bacteria 
(Escherichia coli 0118:H8) exactly as described previously (Zhou et al., 2016a). Data are 
reported as percentages of CD14- and CH138A-positive cells with phagocytosis and 
oxidative burst capability. 
Liver tissue total and oxidized GSH were measured using a commercial kit (Cat. 
No. NWH-GSH01; Northwest Life Science Specialties LLC, Vancouver, WA). Reduced 
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GSH was calculated as reduced GSH = total GSH – oxidized GSH. 
Statistical Analysis 
Data were analyzed using the MIXED procedure of SAS v.9.4 (SAS Institute, Inc. 
Cary, NC) according to the following model with repeated measures: 
Yijkl = μ + bi + Mj + Tk + MTjk + cl (bi) + eijkl, 
where Yijk = dependent, continuous variable, μ = overall mean, bi = random effect of block 
(i = 1 to 7), Mj = fixed effect of treatment (j = Control vs. ethyl-cellulose RPM), Tk = fixed 
effect of time (d or wk), MTmk = interaction between treatment and time (treat  time), cl 
(bi) = random effect of cow within block, eijkl = residual error. The covariates for parity, 
previous 305-d milk yield, and BCS at -30 d relative to parturition were kept in the model 
for all variables when significant (P ≤ 0.15). For the blood analysis, plasma data at -30 d 
relative to parturition were included as a covariate when significant. Unless otherwise 
specified, first-order autoregressive was the covariate structure used for analysis because 
it resulted in the lowest Bayesian information criterion for most of the variables measured. 
Normality of the residuals was checked with normal probability and box plots. Data were 
log2-scale transformed if needed to comply with normal distribution of residuals. The tables 
and graphs contain the log2 back-transformed means that resulted from the statistical 
analysis. Significance was determined at P ≤ 0.05 and tendencies at P ≤ 0.10.  
RESULTS AND DISCUSSION 
Biomarkers of liver function 
During the periparturient period, cows experience a number of stressful events 
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including regrouping, dietary changes, parturition, and the onset of lactation (Trevisi et al., 
2016). Under normal physiological conditions the liver synthesizes and releases into the 
blood proteins and enzymes that can be used as biomarkers of liver function (Ferre et al., 
2002; Bertoni et al., 2008). Main effects of ethyl-cellulose RPM, time, and interactions on 
liver function biomarkers are presented in Table 3.3. Ethyl-cellulose RPM increased 
plasma paraoxonase (P < 0.01) and cholesterol (P = 0.02) after parturition, while a 
tendency (P = 0.07) of treatment × time was observed for cholesterol due to an increase 
over time in the ethyl-cellulose RPM group (Figure 2.1). Aspartate aminotransferase and 
bilirubin were not affected by treatments (P ≥ 0.15). 
Similar to our results, a recent study reported that although basal plasma 
paraoxonase concentration decreased soon after parturition, cows supplemented with RPM 
during the peripartal period had greater liver synthesis of paraoxonase during the 
postpartum period (Zhou et al., 2016a). Although the higher plasma concentrations of 
cholesterol in the ethyl-cellulose RPM group can reflect in part the greater DMI of those 
cows, its response together with the higher plasma concentrations of paraoxonase and 
lower γ-glutamyl transferase (Batistel et al., 2017b), indicate that ethyl-cellulose RPM 
supplementation was able to ameliorate liver function during the postpartum period. 
During the transition to lactation, the metabolic activity of liver increases 
substantially in large part to help meeting the nutrient requirements for milk synthesis.  The 
glucose requirement has been estimated at 1.2 kg/d 3 weeks prior to calving and increases 
to 3 kg/d as a result of hepatic gluconeogenesis at 3 weeks postpartum when milk 
production is around 36 kg/d (Reynolds et al., 2003; Aschenbach et al., 2010). The liver 
also is essential for the metabolism of non-esterified fatty acids taken up due to the 
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extensive mobilization of adipose depots (Drackley et al., 2001). Thus, cows with optimal 
liver function are able to surpass the peripartal period more efficiently and exhibit signs of 
reduced inflammation, oxidative, and metabolic stress (Bionaz et al., 2007; Bertoni et al., 
2008).  
Biomarkers of inflammation 
Main effects of ethyl-cellulose RPM, time, and interactions on inflammation 
biomarkers are presented in Table 3.3. The inflammatory process is a well-conserved 
mechanism to overcome adverse stimuli and restore homeostasis. Dairy cows experience 
some degree of inflammation after parturition (Bertoni et al., 2004; Humblet et al., 2006; 
Sordillo, 2016). A retrospective study where cows were classified by degree of liver 
inflammation based on plasma concentrations of acute-phase proteins indicated that 
inflammation increases the risk of transition disorders and impairs animal performance 
during early lactation (Bertoni et al., 2008). In a recent review, (Bradford et al., 2015) 
proposed that the duration of the inflammatory process rather than its complete avoidance 
is one of the normal adaptations to lactation. Therefore, measuring the consequences of 
inflammatory conditions in the peripartum period is of importance (Trevisi et al., 2016). 
Among the inflammation biomarkers measured, ethyl-cellulose RPM led to greater (P < 
0.01) albumin (negative acute-phase protein) and lower haptoglobin (P < 0.01; Figure 2.2) 
than control. This marked decrease in the concentration of haptoglobin by d 21 postpartum 
in ethyl-cellulose RPM supplemented cows indicates that they were able to control better 
the inflammatory response. Additionally, the higher concentration of plasma albumin 
(negative acute phase protein) as well as cholesterol and paraoxonase, which are also 
biomarker of anti-inflammatory response, in ethyl-cellulose RPM cows supports the idea 
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that they were under a less pronounced inflammatory state (Trevisi et al., 2011; Grossi et 
al., 2013). Myeloperoxidase tended (P = 0.15) to be higher in the ethyl-cellulose RPM 
group compared with control cows. Ceruloplasmin (positive acute phase protein) and 
alkaline phosphatase were not affected by ethyl-cellulose RPM supply. For cytokines, a 
main effect with greater IL-6 in ethyl-cellulose RPM-supplemented cows was detected (P 
= 0.05), while the concentration of IL-1β was not affected (P > 0.10) by ethyl-cellulose 
RPM supply. Because IL-6 has proinflammatory and anti-inflammatory properties (Xing 
et al., 1998; Scheller et al., 2011), the albumin and haptoglobin profiles suggest that in 
ethyl-cellulose RPM cows it might have exerted an anti-inflammatory effect. A similar 
pattern of IL-6 was observed when periparturient cows received a different source of RPM 
(Zhou et al., 2016a). 
Biomarkers of oxidative stress 
Main effects of ethyl-cellulose RPM, time, and interactions are presented in Table 
3.3. Compared with control, cows supplemented with ethyl-cellulose RPM had greater 
plasma concentration of FRAP (P = 0.04) and lower concentration of ROM (P = 0.01; 
Figure 2.3). The higher plasma concentration of ROM in the postpartum period was 
expected because in conditions of high metabolic demands the production of free radicals 
is enhanced partly due to the increase in oxygen requirements (Sordillo and Aitken, 2009). 
Excessive and rapid production of free radicals can cause an imbalance between ROM 
concentrations and antioxidant mechanisms often leading to an increase in oxidative stress. 
The lower plasma concentration of ROM in cows supplemented with ethyl-cellulose RPM 
indicates less pronounced oxidative stress status, and agrees with the profiles of 
inflammation biomarkers. 
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Compared with control, cows supplemented with ethyl-cellulose RPM had greater 
plasma concentration of β-carotene, and tocopherol (P < 0.02; Figure 2.3). These results 
partly reflect the greater dry matter intake in RPM cows (Batistel et al., 2017b). The greater 
concentrations of those vitamins, together with greater plasma concentration of FRAP, is 
positively associated with antioxidant activity (Benzie and Strain, 1996; Trevisi et al., 
2011). Additionally, retinol concentration was not different between groups (P = 0.18). 
In addition, compared with control, cows supplemented with ethyl-cellulose RPM 
had higher concentrations of total glutathione and reduced glutathione in plasma (P < 0.01; 
Figure 2.3). These data reinforce the conclusion that cows fed ethyl-cellulose RPM 
experienced less oxidative stress. Glutathione performs a vital function quenching free 
radicals and detoxifying xenobiotics (Wu et al., 2004b). The GSH produced in liver can be 
utilized within the tissue or exported into the circulation where it can aid in the control of 
oxidative stress. Taken together, our results underscore the importance of methionine as a 
key player in the oxidative stress response acting as a scavenger of ROM as previously 
observed in vitro (Campbell et al., 2016) and in dairy cows during the periparturient period 
(Osorio et al., 2014b; Sun et al., 2016; Zhou et al., 2016a). 
In Vitro Whole Blood Phagocytosis and Oxidative Burst 
Main effects of ethyl-cellulose RPM, time, and interactions are presented in Table 
3.4. Upon challenge, a greater (P = 0.04) increase in neutrophil phagocytosis capacity was 
detected in cows supplemented with ethyl-cellulose RPM (Table 3.4, Figure 3.4). 
Furthermore, ethyl-cellulose RPM-supplemented cows tended to have greater blood 
neutrophil oxidative burst (P = 0.06) compared with control cows. In contrast, monocyte 
phagocytosis and oxidative burst did not change in response to ethyl-cellulose RPM 
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supplementation (P ≥ 0.12). Neutrophils and macrophages are the first line of defense of 
the innate immune system by phagocytosing, killing, and digesting invading pathogens. 
Because the activation of the immune system is an energy-dependent process, the greater 
dry matter intake in ethyl-cellulose RPM (Batistel et al., 2017) could have contributed, at 
least in part, to the observed response in neutrophils. Furthermore, the lower concentrations 
of ROM together with the similar concentration of myeloperoxidase in ethyl-cellulose 
RPM cows could be taken as an indication of more efficient neutrophil function, i.e. 
neutrophils from RPM-fed cows had sufficient supply of glucose for oxidative burst and 
the proper level of antioxidant defenses because elevated ROM could be detrimental to 
immune cells (Spears and Weiss, 2008).  
There is little evidence demonstrating that methionine per se alters immune 
function. However, the efficacy of methionine supply is supported by the 
immunomodulatory capacity of its metabolites (taurine, GSH and homocysteine) (Grimble, 
2006). For instance, in vivo models demonstrated that taurine supplementation enhanced 
neutrophil phagocytic and bactericidal capacity (Masuda et al., 1984), while GSH helped 
sustain the oxidative burst response (Yan et al., 2012). Taken together, the present and 
previous data (Zhou et al., 2016a) underscore the role of methionine supply on neutrophil 
function in periparturient cows. 
CONCLUSIONS 
Overall, the changes observed in plasma biomarkers indicate that feeding ethyl-
cellulose RPM to achieve a ratio of 2.8:1 Lys to Met during the periparturient period and 
early lactation is an effective approach to help mitigate oxidative stress and inflammation 
as well as enhance liver and neutrophil function. Our results indicate that the positive effect 
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on postpartal cow performance is likely due, at least in part, to a better imune response. 
Furthermore, the lower inflammatory and oxidative stress after parturition could lead to 




Table 3.1 Ingredient and nutrient composition of far-off (from -45 to -29 d), close-up (from -28 to 
parturition), fresh (from 1 to 30 DIM) and high-producing (from 31 to 60 DIM) diets. 
  Diet 
Ingredient, % of DM Far-off Close-up Fresh High production 
Alfalfa haylage - 6.55 7.81 10.8 
Corn silage 34.7 26.6 31.0 31.9 
Wheat straw 33.7 26.5 3.25 - 
Corn grain, ground, dry - 12.6 22.21 20.7 
Cottonseed - - 2.17 1.83 
Molasses, beet sugar - 4.03 5.50 4.51 
Soybean hulls 15.7 3.46 4.25 9.96 
Soybean meal, 48% CP 12.0 7.83 10.1 7.98 
Expeller soybean meal1 - 5.80 5.16 5.17 
Protein supplement2 - 0.78 1.81 1.58 
Urea 0.46 0.59 0.39 0.40 
Soychlor3 - 1.23 - - 
Saturated fat supplement4 - - 2.25 2.14 
Limestone - - 1.41 0.96 
Salt 0.40 - 0.02 0.04 
Dicalcium phosphate 0.50 0.52 1.17 0.92 
Magnesium oxide - - 0.08 0.04 
Magnesium sulfate 1.90 2.08 0.02 - 
Sodium Bicarbonate - - 0.84 0.59 
Mineral vitamin mix5 0.40 0.17 0.17 0.20 
Vitamin A6 - 0.03 0.02 0.02 
Vitamin D7 - 0.03 - - 
Vitamin E8 0.40 0.60 - - 
Biotin9 - 0.70 0.42 0.32 
Momensin10 0.01 - - - 
Ethyl-cellulose RPM11 - 0.09 0.10 0.10 
1SoyPlus, West Central Soy, Ralston, IA. 
2ProVAAl AADvantage, Perdue AgriBusiness, Salisbury, MD. 
3West Central Soy, Ralston, IA. 
4Energy Booster 100, Milk Specialties Global, Eden Prairie, MN. 
5Contained a minimum of 5% Mg, 10% S, 7.5% K, 2.0% Fe, 3.0% Zn, 3.0% Mn, 5,000 mg of Cu/kg, 250 mg of I/kg, 40 
mg of Co/kg, 150 mg of Se/kg, 2,200 kIU of vitamin A/kg, 660 kIU of vitamin D3/kg, and 7,700 IU of vitamin E/kg. 
6Contained 30,000 kIU/kg. 
7Contained 5,000 k IU/kg. 
8Contained 44,000 kIU/kg. 
9ADM Animal Nutrition, Quincy, IL. 
10Rumensin, Elanco Animal Health, Greenfield, IN. 
11 Ethyl-cellulose rumen-protected methionine, Evonik Nutrition & Care GmbH, Hanau-Wolfgang, Germany. Only 
added in the treatment group. 
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Table 3.2 Nutrient composition and diet evaluation using the NRC (2001) of prepartal and postpartal diets fed to multiparous Holstein cows 
supplemented with ethyl-cellulose rumen-protected methionine (RPM). 
 
Far-off 
Close up Fresh High production 
 Control RPM Control RPM Control RPM 
Chemical composition, % DM1        
  CP 13.9 ± 0.25 15.6 ± 0.32 15.7 ± 0.32 17.7 ± 0.36 17.7 ± 0.36 17.4± 0.36 17.6 ± 0.36 
  NDF 54.5 ± 0.75 40.8 ± 0.68 40.7 ± 0.68 29.2 ± 0.59 29.3 ± 0.59 31.4 ± 0.62 31.3 ± 0.62 
  ADF 36.9 ± 0.65 27.5 ± 0.50 27.4 ± 0.50 19.5 ± 0.38 19.6 ± 0.38 21.5 ± 0.48 21.4 ± 0.48 
  NFC 24.7 ± 0.72 34.9 ± 0.81 34.9 ± 0.81 41.4 ± 0.55 41.4 ± 0.55 40.7 ± 0.54 40.9 ± 0.54 
  Ether extract 1.81 ± 0.04 2.32 ± 0.05 2.33 ± 0.05 5.12 ± 0.14 5.11 ± 0.14 5.13 ± 0.14 5.15 ± 0.14 
Calculated with NRC (2001)2        
  NEL, Mcal/kg of DM 1.33 1.47 1.47 1.67 1.67 1.6 1.6 
  NEL allowable milk, kg/d - - - 32.3 34.8 42.8 45.3 
  MP allowable milk, kg/d - - - 38.8 40.8 49.4 51.7 
  RDP, % of DM 8.8 9.4 9.4 10.2 10.2 9.9 10 
  RUP, % of DM 5.1 6.2 6.3 7.4 7.5 7.4 7.6 
  RDP balance, g/d 8 10 7 11 9 3 7 
  RUP balance, g/d 537 673 794 -138 -191 -28 -128 
  MP balance, g/d 421 555 664 -118 -160 -23 -66 
  Lys, % of MP 6.74 6.54 6.51 6.40 6.38 6.33 6.29 
  MP-Lys, g 82 89 89 155 156 194 195 
  Met, % of MP 1.77 1.73 2.30 1.70 2.24 1.68 2.22 
  MP-Met, g 21 24 32 41 56 52 68 
  Lys: Met 3.81:1 3.71:1 2.81:1 3.78:1 2.88:1 3.78:1 2.82:1 
1Mean ± standard deviation. 
2 The NRC (2001) evaluation of diets was based on final averaged pre- and postpartum DMI, production data, and feed analysis. 
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Table 3.3 Effects of ethyl-cellulose rumen-protected methionine (RPM) supplementation to multiparous 
Holstein dairy cows during the close-up period (from -28 d to parturition), fresh (from 1 to 30 DIM) and 
high-producing (from 31 to 60 DIM) periods on plasma biomarkers of liver function, inflammation and 
oxidative stress. 
Item  Control RPM SEM 
P value 
Treatment1 Time Treat × Time 
Liver function       
  Aspartate aminotransferase, U/L 85.4 95.1 6.01 0.89 <0.01 0.92 
  Bilirubin, µmol/L 3.74 3.39 0.34 0.48 <0.01 0.80 
  Cholesterol, mmol/L 3.50 4.04 0.11 0.02 <0.01 0.46 
  Paraoxonase, U/mL 84.0 94.8 3.54 <0.01 <0.01 0.36 
Inflammation       
  Alkaline phosphatase, U/L 57.4 56.1 1.53 0.57 <0.01 0.77 
  Albumin, g/L 36.4 38.1 0.38 <0.01 <0.01 0.48 
  Ceruloplasmin, µmol/L 2.65 2.67 0.09 0.82 <0.01 0.32 
  Haptoglobin, g/L 0.55 0.46 0.04 0.05 <0.01 0.27 
  Myeloperoxidase, U/L 362 380 6.04 0.15 <0.01 0.45 
  IL-6, pg/mL 672 874 94.9 0.05 0.02 0.46 
  IL-1β, pg/mL 5.21 4.89 1.15 0.24 <0.01 0.57 
Oxidative stress       
  FRAP2, µmol/L 139 144 3.45 0.04 <0.01 0.92 
  ROM3, H2O2/100 mL 16.8 16.1 0.31 0.01 <0.01 0.95 
  β-carotene, mg/100 mL 0.19 0.23 0.02 0.02 0.01 0.33 
  Retinol, µg/mL 27.0 28.4 0.72 0.18 0.19 0.96 
  Tocopherol, µg/mL 4.54 5.15 0.23 0.01 <0.01 0.22 
  Glutathione, µmol/g protein 37.5 59.5 9.54 <0.01 <0.01 0.26 
  Reduced glutathione, µmol/g protein 36.4 58.1 9.49 <0.01 <0.01 0.28 
1Ethyl-cellulose rumen-protected methionine effect. 
2Ferric-reducing ability of plasma  
3Reactive oxygen metabolites
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Table 3.4 Effects of ethyl-cellulose rumen-protected methionine (RPM) supplementation to multiparous 
Holstein dairy cows during the close-up period (from -28 d to parturition), fresh (from 1 to 30 DIM) and 
high-producing (from 31 to 60 DIM) periods on blood neutrophil and monocyte function. 
Item  Control RPM SEM 
P value 
Treatment1 Time Treat × Time 
Neutrophils       
  Phagocytosis 49.7 59.4 3.07 0.04 0.25 0.77 
  Oxidative burst 44.6 53.1 3.92 0.06 0.38 0.85 
Monocytes       
  Phagocytosis 43.9 48.1 2.95 0.12 0.12 0.59 
  Oxidative burst 25.2 24.5 2.84 0.21 0.22 0.87 
1Ethyl-cellulose rumen-protected methionine effect. 
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Figure 3.1 Effect of ethyl-cellulose rumen-protected methionine (RPM) supplementation to 
multiparous Holstein cows from -28 through 60 days in milk on plasma biomarkers of liver 
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Figure 3.2 Effect of ethyl-cellulose rumen-protected methionine (RPM) supplementation to 
multiparous Holstein cows from -28 through 60 days in milk on plasma biomarkers of 
inflammation. (A: albumin; B: haptoglobin; C: interleukin-1β; D: interleukin-6). Values represent 
the means ± SEM. 
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Figure 3.3 Effect of ethyl-cellulose rumen-protected methionine (RPM) supplementation to 
multiparous Holstein cows from -28 through 60 days in milk on plasma and liver biomarkers of 
oxidative stress (A: ferric-reducing ability of plasma; B: reactive oxygen metabolites; C: β-
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Figure 3.4 Effect of ethyl-cellulose rumen-protected methionine (RPM) supplementation to 
multiparous Holstein cows from -28 through 60 days in milk on neutrophil phagocytosis (A) and 
oxidative burst (B). Values represent the means ± SEM. 
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In dairy cows, the final trimester of gestation is characterized by marked fetal growth, and 
proper placental transfer of nutrients is required to ensure adequate fetal development (NRC, 
2001). Besides maternal nutrient availability, it is well-established in non-ruminants that 
expression and activity of specific transporters in the placenta influence the transport of nutrients 
from maternal to fetal circulation (Jones et al., 2007). The anatomical structure of the placenta 
precludes direct contact of maternal and fetal blood, emphasizing the importance of protein 
transporters, concentration gradients and diffusion channels for membrane nutrient exchange 
(Brett et al., 2014).  
In bovine, the areas of maternal-fetal interface are limited to discrete round structures 
named placentomes, which consist of maternal caruncles interdigitating with fetal cotyledons 
(Schlafer et al., 2000; Bridger et al., 2007). In order to reach the fetal blood, nutrients from 
maternal circulation must surpass the syncytiotrophoblasts (Firth, 1966), which contain two 
polarized membranes, the microvillus membrane facing maternal circulation and the basal plasma 
membrane facing the fetal vascular structure (Brett et al., 2014). Both membranes have low 
permeability, hence, constituting rate-limiting steps for the transport of medium and large 
substrates into fetal circulation (Brett et al., 2014). Consequently, nutrients are predominantly 
absorbed and translocated into fetal circulation by nutrient-specific transport proteins situated 
within the microvillous membrane and basal plasma membrane (Lager and Powell, 2012). 
Recent studies with livestock underscored the potential impact of maternal methyl donor 
nutrition on the offspring. Betaine (Cai et al., 2014) and folic acid (Liu et al., 2011) 
supplementation to pregnant sows elicited a programming effect on the offspring, e.g., increased 
gluconeogenesis and immune response in newborn piglets. In dairy cows, a recent study from our 
laboratory revealed that increasing the supply of methionine [0.8 g·kg-1 of dry matter intake 
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(DMI) of the diet; 6-7 g extra of methionine available for absorption] during the last 30 days of 
pregnancy enhanced the maturation of gluconeogenesis and fatty acid oxidation in the neonatal 
calf liver, which would be advantageous for adaptation to the metabolic demands of extrauterine 
life (Li et al., 2016). Furthermore, 6.3 g per day of rumen-protected methionine throughout the 
last 41 days of gestation tended to increase the birthweight of lambs (Liu et al., 2016). Besides 
these effects, it also is noteworthy that excess homocysteine concentration (a metabolite of 
methionine) impairs placental metabolism and function as well as fetal development (Di Simone 
et al., 2003; Tsitsiou et al., 2011; Bergen et al., 2012). 
Besides performing an indispensable function delivering essential nutrients for fetal 
growth, placental tissue (as other mammalian cells) has an array of additional nutrient-sensing 
signaling pathways such as the mammalian target of rapamycin (mTOR) complex (Jansson et al., 
2013). For instance, in humans, mTOR alters the activity of placental amino acid (AA) 
transporters in response to the level of nutrient supply (Roos et al., 2009b). Thus, we hypothesized 
that increasing maternal methionine supply during late-pregnancy could improve placental 
nutrient transport at least in part via mTOR signaling. The objective of this study was to determine 
the effect of rumen-protected methionine supplementation during the last 28 days of pregnancy 
on gene and protein expression of nutrient transporters and mTOR pathway in utero-placental 
tissue of dairy cows. 
METHODS 
Animals, experimental design and treatments  
The Institutional Animal Care and Use Committee at University of Illinois (Urbana; 
protocol # 14270) approved all the experimental procedures. Details of the experimental design 
have been reported previously (Batistel et al., 2017b). Briefly, sixty multiparous Holstein cows 
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were used in a randomized, complete block design experiment with 30 cows per treatment. 
Cows were blocked by the expected day of parturition, and the blocks were balanced by parity, 
previous 305-days milk yield, and body condition score. The body condition score used to 
block cows was measured at -30 d before parturition using the scale 1 to 5 (1 = thin, 5 = fat 
scale in 0.25 increments) (Wildman et al., 1982). Cows were fed the experimental treatments 
consisting of a basal control (Control; n = 30; 1.47 Mcal·kg-1 of dry matter) diet with no added 
methionine or the basal diet plus ethyl-cellulose rumen-protected methionine (Methionine; 
Mepron®, Evonik Nutrition & Care GmbH, Germany; n = 30) during the last 28 days of 
pregnancy. The methionine product was supplied (top-dressed) at a rate of 0.9 g·kg-1 of DM on 
the total mixed diet. This supply of methionine was based on recent experiments demonstrating 
a benefit of achieving a Lysine:Methionine ratio close to 2.8:1 in terms of production 
performance and health (Osorio et al., 2013; Zhou et al., 2016b). Mepron® is a commercial 
rumen-protected source of DL-methionine which resists ruminal degradation through an 
ethylcellulose film coating. Pellets measure 1.8 × 3 mm and contain 85% DL-methionine. 
Mepron® contains an equimolar mixture of the D- and L-isomers and a minimum of 75 ± 3% of 
the ingested D-methionine is transformed into L-methionine by the dairy cow (Lapierre et al., 
2012). The intestinal digestibility coefficient and ruminal bypass value of Mepron is 90% 
(Schwab, 1995) and 80% (Overton et al., 1996); therefore, per 10 g of Mepron, the cows 
received 6.1 g methionine available for absorption. During the preliminary period (from -45 to -
29 days relative to the expected parturition day) all cows received the same diet containing 1.33 
Mcal·kg-1 of DM with no added methionine. Treatment diets were mixed daily in a tumble-
mixer and fed once daily (1300 h). The ingredients and chemical composition of the diets are 
reported in Table 3.1. Diets were formulated to meet cow’s predicted requirements for energy, 
protein, minerals and vitamins according to the National Research Council (NRC) (NRC, 
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2001). Calves were weighed soon after parturition (~30 min) and before colostrum consumption 
(Control, n = 39; Methionine n = 42). 
Blood sample collection  
Blood samples from cows was collected from the coccygeal vessel before the morning 
meal at -7 days relative to expected parturition, while samples from calves were taken from the 
jugular vessel within 1 h after parturition and before colostrum intake. Samples were collected 
into evacuated tubes (BD Vacutainer, BD and Co.) containing lithium heparin. After collection, 
samples were placed on ice until centrifugation (~40 min). Plasma was obtained by centrifugation 
at 2,000 × g for 30 min at 4 °C. Aliquots of plasma were frozen (-80 °C) until further analysis. 
Placentome collection 
After the natural delivery of the placenta, four placentomes from the central area of the 
placenta were dissected, rinsed with physiological saline, and stored at -80°C until analysis. 
Subsamples were used to perform RNA extraction and protein extraction. Samples were chosen 
based on the following criteria: number of parities, body condition score (Wildman et al., 1982) 
of the cows at day -30 relative to the expected parturition, number of days that the cows received 
the respective diet, absence of twins at parturition, release of the placenta within 14 hours after 
parturition, and calf sex (Online Supporting Material). 
Laboratory analyses 
Insulin and Amino Acids. Plasma insulin concentrations were determined using a bovine-
specific commercial ELISA kit (catalog no. 10-1201-01, Mercodia). Plasma amino acid 
concentration analysis was according to established protocols (AOAC, 1995). 
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RNA isolation, cDNA Synthesis and Quantitative PCR. Total RNA was isolated from 100 mg 
of placentome tissue using the miRNeasy kit (Qiagen) following the manufacturer’s protocols. 
Samples were treated on-column with DNaseI (Qiagen); quantification was accessed using the 
NanoDrop ND-1000 (NanoDrop Technologies), and RNA quality was measured using an Agilent 
2100 Bioanalyzer (Agilent). All samples had an RNA integrity number factor greater than 7. The 
qPCR was performed as described previously (Osorio et al., 2014a). qPCR performance and 
primer information are included in the Online Supporting Material. 
Western blot analysis. Total protein was extracted using tissue protein extraction reagent (catalog 
no. 78510; Thermo Scientific), which included inhibitor Cocktail (100x, catalog no. 78442; 
Thermo Scientific). The concentrations of total protein were determined with the BCA assay kit 
(catalog no. 23227; Thermo Scientific). Protein samples were boiled at 100 °C for 10 min; 80 µg 
of total protein per lane was resolved by SDS-PAGE and then transferred to PVDF membrane 
(catalog no. 1620261; Bio-Rad) by using the semi-dry transfer assembly (Bio-Rad). Membranes 
were blocked in Tris-buffered saline (TBST; 50 mM Tris, pH 7.6, 150 mM NaCl, and 0.1% 
Tween 20) which contains 5% (w/v) nonfat milk for 2 h at room temperature with gentle agitation. 
The membranes were then incubated in TBST with 5% nonfat milk containing antibodies to 
mTOR, p-mTOR, S6K1, p-S6K1, 4EBP1, p-4EBP1, eIF2a, p-eIF2a, eEF2, p-eEF2, AKT and p-
AKT (catalog no. 2972A, 2971S, 9202S, 9234S, 9452S, 9459S, 5324P, 3398S, 2332S, 2331S, 
9272S, and 9272S, respectively; Cell Signaling Technology) with gentle agitation at 4 °C 
overnight. After incubating with primary antibody, the membranes were washed and incubated 
with HRP-conjugated secondary antibodies (catalog no. ab6721; Abcam) in TBST for 1 h at room 
temperature. The membranes were washed and then incubated with ECL reagent (catalog no. 
170-5060; Bio-Rad). GAPDH (catalog no. ab22555; Abcam) and tubulin (catalog no. 2144S; Cell 
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Signaling Technology) were the internal controls. The images were captured using ChemiDOC 
MP (Bio-Rad). The intensities of the bands were measured with Image-Pro Plus 6.0 software. 
Enzyme activity assay. Betaine homocysteine methyltransferase (BHMT) activity was measured 
as described by Garrow (Garrow, 1996). 
Statistical analysis  
The complete data set of cows (Control, n = 30; Methionine n = 30) and calves (Control, 
n = 39; Methionine = 42) were used to analyze animal performance. In doing so we ensured 
appropriate biological replication to detect small changes in these phenotypes that inherently have 
higher variability. The data were analyzed using the MIXED procedure of SAS 9.4 (SAS 
Institute) according to the following model: 
Yij = μ + bi + Mj + eij, 
where Yij = dependent, continuous variable, μ = overall mean, bi = random effect of block (i = 1 
to 7), Mj = fixed effect of treatment (j = control versus methionine), eij = residual error. For the 
analysis of DMI, the average intake of individual cows during the preliminary period was used 
as covariate in the model. For gene and protein expression, the data were log-2 transformed 
before the analysis. Normality of the residuals was checked with normal probability and box 
plots and homogeneity of variances with plots of residuals versus predicted values. Data are 
presented as least-squares means with pooled SEMs. Significance was declared at P < 0.05. 
RESULTS 
Animal performance, plasma amino acids and enzyme activity 
Cows supplemented with methionine averaged 1.2 kg · d-1 more DMI (P = 0.01) during 
the treatment period (Figure 4.1a). Furthermore, methionine-supplemented cows had greater (P 
81 
 
= 0.04) plasma insulin concentration (Figure 4.1b), and their calves had greater (P = 0.04) body 
weight at birth (Figure 4.1c). Compared with controls, increasing methionine supply enhanced 
plasma concentration of methionine (P = 0.01) and alanine (P = 0.08) as well as BHMT activity 
(P = 0.08) in the placentome (Table 4.2). Methionine supply did not affect the plasma 
concentrations of histidine, isoleucine, leucine, lysine, threonine, valine, arginine, asparagine, 
aspartic acid, cysteine, glutamic acid, glutamine, glycine, proline, serine and tyrosine. None of 
the amino acids measured in calf plasma were affected (data not shown) by maternal methionine 
supply. Plasma concentrations of homocysteine in cows and calves were below the threshold of 
detection. 
Gene expression 
Amino acid transporters. Compared with controls, increasing methionine supply resulted in 
greater mRNA expression of genes involved in the System A (SLC38A1, P = 0.05; SLC38A2, P 
= 0.09; and SLC38A10, P = 0.07) and System L (SLC3A2, P = 0.05; and SLC7A5, P = 0.01) AA 
transport. In contrast, SLC43A2 (System L) was downregulated (P = 0.05) in cows supplemented 
with methionine than controls (Table 4.3). The genes SLC1A1, SLC1A5, SLC6A6, SLC7A8, 
SLC38A6, SLC38A7 and SLC38A11 that encode AA transporters were not affected by supply of 
methionine. 
Glucose transporters. Among glucose transporters analyzed, the facilitated transporters SLC2A1 
(P = 0.06), SLC2A3 (P = 0.05) and SLC2A4 (P = 0.07) had greater mRNA expression in response 
to increased methionine supply, while SLC2A8 was lower (P = 0.07) than control cows (Table 
4.3). Other glucose transporters (SLC2A5, SLC2A6, SLC2A9, SLC2A10, SLC2A11, SLC2A12, 
SLC2A13 and SLC5A11) analyzed were not affected by increased methionine supply. 
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Fatty acids transporters. Regarding the fatty acid transporters, increasing the methionine supply 
resulted in lower (P = 0.06) expression of SLC27A1, while SLC27A2 and SLC27A3 were not 
affected compared with controls (Table 4.3). 
Vitamin transporters. The sodium/multivitamin and iodine cotransporter (SLC5A6) had greater 
expression (P = 0.09) in response to methionine (Table 4.3). However, the vitamin transporters 
SLC19A2, SLC19A3, SLC44A1 and SLC44A3 were not affected. The expression of the betaine 
transporter (SLC6A12) was lower (P = 0.06) in response to increasing methionine supply 
compared with controls. 
mTOR pathway gene and protein expression  
MTOR (P = 0.04) and RPS6KB1 (P = 0.07) had greater mRNA expression in response to 
increased methionine supply compared with controls, whereas AKT1, EIF4EBP1, EIF4EBP2, 
EEF1A1, ELF2 and IRS1 expression was not altered (Table 4.3). 
Western blot analysis of mTOR, p-mTOR, S6K1, p-S6K1, 4EBP1, p-4EBP1, eIF2a, p-
eIF2a, eEF2, p-eEF2, AKT and p-AKT proteins revealed that increasing methionine supply 
resulted in greater mTOR (P = 0.09), AKT (P = 0.09), p-mTOR (P = 0.08), p-AKT (P = 0.08) 
and p-eEF2 (P = 0.02) expression compared with controls (Table 4.3). The ratio of p-
mTOR/mTOR was greater (P = 0.06) in response to enhanced methionine supply. We were 
unable to detect p-S6K1 and p-4EBP1. Other proteins were not affected by the increased supply 
of methionine. 
DISCUSSION 
Adequate fetal growth is essential for progeny development and can have lifelong 
consequences (Wu et al., 2004a). Maternal availability of nutrients and efficiency of transport by 
placenta are major intrauterine factors influencing fetal development (Brett et al., 2014). The 
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activity and availability of nutrient-specific transporters, which may be affected by maternal 
nutrition, determine the extent to which substrates cross the placenta and enter the fetal circulation 
(Lager and Powell, 2012; Brett et al., 2014). Furthermore, evidence indicates that mTOR acts as 
a placental nutrient sensor with the capacity to alter the activity of nutrient transporters. 
Animal performance. In humans, Gaccioli et al. proposed that the placenta responds to maternal 
and fetal nutritional signals with information from intrinsic nutrient sensing signaling pathways. 
Among other things, these pathways balance fetal demand with the ability of the mother to 
support the pregnancy by regulating nutrient transport (Gaccioli et al., 2013). The fact that greater 
birth weight matched the greater plasma methionine concentration is suggestive that a similar 
mechanism might be present in cattle. As such, despite using current nutritional recommendations 
(1), the control diet and the lower dry matter intake during the last 2-3 weeks prepartum might 
have limited fetal growth. Hence, we speculate that the greater DMI when methionine supply 
increased played a role in enhancing not only delivery of methionine but other non-dispensable 
AA and nutrients to the placenta. As such, nutrient transporter expression was upregulated. 
 Activity of BHMT, which remethylates homocysteine to methionine, regulates 
homocysteine levels in the liver (Ji et al., 2007). Thus, the inability to detect concentrations of 
homocysteine in plasma along with greater BHMT activity in response to greater methionine 
supply and DMI indicate that the level of supplemental methionine in the diet did not elicit a toxic 
effect. 
Amino acid transport. Amino acid transport across cellular membranes occurs through active 
transport processes, generally classified into accumulative transporters and exchangers. 
Accumulative transporters enhance AA concentrations by driving influx against their 
concentration gradient, commonly by co-transporting extracellular sodium while exchangers alter 
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the intracellular AA composition by swapping between intra- and extra-cellular compartments 
(Lager and Powell, 2012). Amino acid transporters can be further categorized into distinct 
systems depending on characteristics such as substrate specificity and sodium dependence, e.g., 
systems A (Sodium dependent) and L (Sodium independent) (Lager and Powell, 2012). The 
greater mRNA expression of genes involved in the system A (SLC38A1, SLC38A2, and 
SLC38A10) in response to increased methionine supply indicates a greater ability for uptake of 
small dispensable neutral AA such as alanine, glycine, and serine (Jansson, 2001). Because 
system A activity is mainly localized in the microvillus membrane, these results suggest a high 
intracellular concentration of dispensable AA.  
Besides the uptake of dispensable AA, system A activity contributes indirectly to 
placental transport of non-dispensable AA (Lager and Powell, 2012). The greater intracellular 
concentration of dispensable AA is important to allow for uptake of non-dispensable AA, e.g., 
leucine and phenylalanine, against their concentration gradient via system L (Verrey, 2003). 
Therefore, the upregulation of SLC3A2 (CD98, system L) and SLC7A5 (LAT1, system L) in 
response to increased methionine supply indicates greater transport of non-dispensable AA. The 
LAT1 (SLC7A5) and CD98 proteins form a heterodimeric transmembrane protein complex that 
catalyzes AA transport (Napolitano et al., 2015). Although SLC7A5 is primarily localized in the 
microvillus membrane, it also can exchange dispensable AA in the fetal compartment with 
cytoplasmic non-dispensable AA in the syncytiotrophoblast cells, hence, performing an essential 
role in the net efflux of AA to the fetus (Kudo and Boyd, 2001; Lager and Powell, 2012). 
Glucose transport. Glucose is the main energy substrate required for fetal and placental growth 
and metabolism. In bovine, fetal gluconeogenesis is marginal, and the fetus is mainly dependent 
on glucose from maternal circulation (Bell, 1995; Gao et al., 2009). Placental transport of glucose 
and other polyols, e.g., fructose, galactose, mannose, maltose, occurs by facilitated diffusion 
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along a concentration gradient through the family of glucose transporters (GLUT) (Baumann et 
al., 2002), GLUT1 (SLC2A1) and GLUT3 (SLC2A3). These transporters have unequal 
distribution across the placental membrane. GLUT1 is predominant in the basal membrane while 
GLUT3 is prevalent in the microvillus membrane, and glucose transport to fetal circulation 
involves sequential action of both transporters (Wooding et al., 2005). The greater plasma insulin 
concentration in the cows as well as the upregulation of the insulin-regulated glucose transporter 
(GLUT4: SLC2A4) in response to increased methionine supply lead us to hypothesize that the 
larger intestinal flow of AA stimulated insulin secretion (Brown et al., 2011), and consequently 
enhanced glucose transport into the placenta. 
Fatty acid transport. At least in non-ruminants, essential fatty acids, e.g., linoleic acid and α-
linolenic acid, and their long-chain polyunsaturated fatty acid derivatives are crucial for fetal 
growth and development (Haggarty, 2002). Triacylglycerol in very-low-density lipoproteins and 
chylomicrons are the major source of fatty acids for the fetus (Haggarty, 2010), and translocation 
from maternal to fetal circulation involves the action of lipoprotein lipase on the capillary 
endothelium (Magnusson et al., 2004). The mechanisms responsible for fatty acid uptake and 
trafficking in the placenta are not completely elucidated. However, evidence from non-ruminant 
work suggests that to some degree cells rely on passive transport of fatty acids (Haggarty, 2010). 
Overall, the lower mRNA expression of SLC27A1, which specifically transports long-chain fatty 
acids, in response to increased methionine supply indicates a decrease in transport of fatty acids. 
Vitamin transport. The upregulation of the sodium-dependent multivitamin transporter 
(SLC5A6) in response to increased methionine supply indicates a greater availability of the water-
soluble vitamins biotin, pantothenic acid, and lipoic acid to the fetus (de Carvalho and Quick, 
2011; Vadlapudi et al., 2012). These nutrients are exclusively dependent on maternal supply, 
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perform roles in the majority of cellular functions and are essential for fetal development 
especially because of the high rate of DNA synthesis associated with rapid cellular turnover 
(Minet et al., 2000). For instance, pantothenic acid and biotin are indispensable cofactors 
involved in a large number of biochemical reactions, including the tricarboxylic acid (Daugherty 
et al., 2002) and gluconeogenesis (Salto et al., 1999). Lipoic acid scavenges free radicals and 
helps maintain the intracellular levels of the antioxidant glutathione (Shay et al., 2009). 
The sodium chloride-dependent betaine transporter 1 (SLC6A12) carries betaine from the 
maternal circulation into the fetal circulation. Betaine is an important methyl donor 
(transmethylation) in the 1-carbon metabolism pathway, which mainly occurs in the liver and 
kidney of the fetus (Dominguez-Salas et al., 2012). We speculate that the lower expression of 
SLC6A12 in response to increased methionine supply occurred because the methyl donor 
requirements for cellular functions such as DNA methylation, phosphatidylcholine synthesis, and 
protein synthesis were met via the direct uptake of methionine (Obeid, 2013). 
mTOR signaling pathway. The mTOR is a conserved serine-threonine kinase located 
downstream of PI3K and AKT1 that regulates cell development and proliferation via activation 
of ribosomal protein S6 kinase (RPS6K) to phosphorylate RPS6 and consequently regulate 
protein synthesis among other functions (Hay and Sonenberg, 2004; Wullschleger et al., 2006). 
At least in non-ruminants, nutrient availability in the maternal circulation (particularly AA) seems 
to be the major upstream regulator of mTOR (Roos et al., 2009b). For instance, in human primary 
trophoblasts, inhibition of mTOR signaling (via rapamycin) decreased the activity of placental 
AA transporters of the system A (-17%; SNAT1, SNAT2 and SNAT4) and L (-28%; LAT1, 
LAT2 and CD98) as well as the taurine transporter (-40%; TAUT) (Roos et al., 2009a). Individual 
AA such as leucine and arginine and glucose can regulate mTOR signaling independently 
(Gonzalez et al., 2012). Because the increased supply of methionine also was associated with 
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greater DMI and plasma insulin of the cows, we speculate that availability of methionine and 
other non-dispensable AA possibly stimulated the mTOR-signaling pathway leading to greater 
AA transport from the maternal to the fetal circulation. Although the number of studies 
addressing mTOR regulation of trophoblast uptake of nutrients such as taurine are increasing 
(Rosario et al., 2013), the exact molecular mechanisms linking mTOR and nutrient transporters 
remain unknown. 
Collectively, the present data and those from published studies with non-ruminant species 
argues for the potential relevance of maternal methionine supply during late-gestation in 
enhancing utero-placental uptake and transport of nutrients. Although the greater birth body 
weight could have been a direct response to greater nutrient supply from the feed intake response 
induced by methionine, the fact that certain AA and glucose are known to induce mTOR signaling 
to different degrees is highly suggestive of “nutrient-specific” mechanistic responses. Additional 




TABLE 4.1 Ingredient and chemical composition of diets fed during preliminary (from day -45 






Ingredient, g · kg-1 DM    
  Alfalfa haylage - 65.5 65.5 
  Corn silage 347 266 266 
  Wheat straw 33.7 265 265 
  Corn grain, ground, dry - 126 1.6 
  Molasses, beet sugar - 40.3 40.3 
  Soybean hulls 157 34.6 34.6 
  Soybean meal, 48% CP 120 78.3 78.3 
  Expeller soybean meal1 - 58.0 58.0 
  Protein supplement2 - 7.80 7.80 
  Urea 4.60 5.90 5.90 
  Soychlor3 - 12.3 12.3 
  Salt 4.00 - - 
  Dicalcium phosphate 5.00 5.20 5.20 
  Magnesium sulfate 19.0 20.8 20.8 
  Mineral vitamin mix4 4.00 1.70 1.70 
  Vitamin A5 - 0.30 0.30 
  Vitamin D6 - 0.30 0.30 
  Vitamin E7 4.00 6.00 6.00 
  Biotin8 - 7.00 7.00 
  Monensin9 0.10 - - 
  Rumen-protected methionine10 - - 0.90 
Chemical composition, g · kg-1 DM    
  Crude protein 139 156 157 
  Neutral detergent fiber 545 408 407 
  Acid detergent fiber 369 275 274 
  Non-fibrous carbohydrate 247 349 349 
  Ether extract 18.1 23.2 23.3 
1SoyPlus, West Central Soy, Ralston, IA. 
2ProvAAl AAdvantage, Perdue AgriBusiness, Salisbury, MD. 
3West Central Soy, Ralston, IA. 
4Composition in kg-1 DM: 50 Mg, 100 S, 75 K, 2.0 Fe, 3.0 Zn, 3.0 Mn, 5 Cu, 0.03 I, 0.04 Co, and 0.15 Se. 
Vitamins in mg kg-1 DM:  retinol 220, cholecaciferol 66, and alpha-tocopherol 770. 
5Contained 0.9 g·kg-1 retinol. 
6Contained 125 g·kg-1 cholecaciferol. 
7Contained 29.5 g·kg-1 alpha-tocopherol. 
8ADM Animal Nutrition, Quincy, IL. 
9Rumensin, Elanco Animal Health, Greenfield, IN. 
10Mepron®, Evonik Nutrition & Care GmbH, Hanau-Wolfgang, Germany.  
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TABLE 4.2 Plasma amino acid concentrations prior to parturition and BHMT activity in 
placentome in response to feeding cows a basal control diet or the basal diet plus ethyl-




SEM P value Control Methionine 
Non-dispensable AA, µM 
  Histidine 38.01 42.52 3.22 0.16 
  Isoleucine 100.6 112.8 9.15 0.19 
  Leucine 137.2 149.4 12.8 0.30 
  Lysine 58.14 67.03 6.15 0.18 
  Methionine 11.90 15.30 1.70 0.01 
  Phenylalanine 38.14 39.35 2.42 0.69 
  Threonine 57.92 66.32 5.87 0.12 
  Valine 222.8 242.4 22.1 0.31 
Dispensable AA, µM 
  Alanine 163.8 187.3 8.97 0.08 
  Arginine 54.53 56.25 4.59 0.75 
  Asparagine 23.46 24.97 3.78 0.56 
  Aspartic acid 8.261 9.015 1.50 0.43 
  Cysteine 0.416 0.416 0.41 0.70 
  Glutamic acid 49.61 46.89 4.07 0.68 
  Glutamine 210.7 236.0 13.6 0.19 
  Glycine 174.4 153.2 30.6 0.55 
  Proline 59.06 60.80 5.21 0.75 
  Serine 48.53 53.28 4.75 0.33 
  Tyrosine 35.32 39.18 3.86 0.45 
Enzyme activity, nmol product · -1 · mg protein-1 
  BHMT 3.61 8.02 2.31 0.08 




TABLE 4.3 mRNA expression of genes related to transport of amino acids, fatty acids, 
glucose and vitamins, and the mTOR pathway in placentome samples from cows fed a basal 
control diet or the basal diet plus ethyl-cellulose rumen-protected methionine (0.9 g·kg-1 of 
dry matter intake) during the last 28 days of pregnancy 
 Treatment   
Gene Control Methionine SEM  P value 
  SLC1A1 1.10 0.98 0.23 0.15 
  SLC1A5 1.16 1.22 0.19 0.21 
  SLC3A2 1.10 1.43 0.15 0.05 
  SLC6A6 1.01 1.22 0.13 0.11 
  SLC7A5 1.35 1.89 0.18 0.01 
  SLC7A8 0.51 0.56 0.16 0.25 
  SLC38A1 0.35 0.75 0.16 0.05 
  SLC38A2 0.48 0.91 0.17 0.09 
  SLC38A6 0.19 0.33 0.38 0.24 
  SLC38A7 0.08 0.06 0.28 0.56 
  SLC38A10 0.10 0.65 0.35 0.07 
  SLC38A11 0.28 0.21 0.12 0.58 
  SLC43A2 1.05 0.75 0.18 0.05 
  SLC2A1 0.85 1.15 0.21 0.06 
  SLC2A3 0.51 0.87 0.16 0.05 
  SLC2A4 2.46 3.51 0.37 0.07 
  SLC2A5 0.19 0.33 0.75 0.36 
  SLC2A6 0.74 0.46 0.53 0.11 
  SLC2A8 1.15 0.60 0.42 0.07 
  SLC2A9 0.38 0.42 0.33 0.58 
  SLC2A10 0.52 0.69 0.32 0.36 
  SLC2A11 0.25 0.13 0.18 0.29 
  SLC2A12 0.32 0.75 0.22 0.12 
  SLC2A13 0.12 0.07 0.19 0.28 
  SLC5A11 0.42 0.98 0.43 0.12 
  SLC27A1 0.72 0.45 0.13 0.06 
  SLC27A2 0.09 0.18 0.15 0.48 
  SLC27A3 0.13 0.12 0.16 0.32 
  SLC5A6 0.12 0.40 0.19 0.09 
  SLC6A12 1.12 0.92 0.19 0.06 
  SLC19A2 0.15 0.08 0.23 0.31 
  SLC19A3 0.18 0.12 0.33 0.45 
  SLC44A1 0.16 0.48 0.34 0.11 
  SLC44A3 0.09 0.26 0.20 0.18 
  SLC46A1 1.06 0.98 0.18 0.24 
  AKT1 0.45 0.65 0.18 0.18 
  MTOR 0.23 0.67 0.20 0.04 
  RPS6KB1 0.46 1.36 0.42 0.07 
  EIF4EBP1 0.58 0.64 0.23 0.34 
  EIF4EBP2 0.34 0.68 0.19 0.12 
  EEF1A1 0.28 0.24 0.23 0.45 
  ELF2 0.47 0.92 0.20 0.13 





TABLE 4.4 Expression of mTOR pathway-related proteins in placentome samples from cows fed 
a basal control diet or the basal diet plus ethyl-cellulose rumen-protected methionine (0.9 g·kg-1 
of dry matter intake) during the last 28 days of pregnancy. 
 Treatment   
Protein Control Methionine SEM  P value 
Total protein1 
  mTOR 11.25 11.68 0.16 0.06 
  S6K1 11.73 11.51 0.31 0.63 
  4EBP1 11.57 11.72 0.33 0.77 
  eIF2a 
eIF2a 
 
11.27 11.64 0.38 0.51 
  eEF2 11.42 11.50 0.17 0.75 
  AKT 10.70 11.45 0.28 0.09 
Phosphorylated protein1 
  p-mTOR 10.53 11.24 0.28 0.08 
  p-S6K12 - - - - 
  p-4EBP12 - - - - 
  p-eIF2a 
 
11.02 11.11 0.35 0.56 
  p-eEF2 10.85 11.35 0.12 0.02 
  p-AKT 10.42 11.43 0.35 0.08 
Ratio 
  mTOR 0.48 0.72 0.08 0.06 
  S6K1 - - - - 
  4EBP1 - - - - 
  eIF2a 
 
0.53 0.61 0.17 0.71 
  eEF2 0.63 0.88 0.13 0.21 
  AKT 0.87 1.08 0.11 0.15 
1Log-transformed data. 
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FIGURE 4.1 Cow dry matter intake (Control, n = 30; Methionine n = 30; A) and plasma insulin 
concentration (Control, n = 15; Methionine n = 15; B), and calf birth body weight (Control, n = 
39; Methionine n = 42; C) in response to feeding cows a basal control diet or the basal diet plus 
ethyl-cellulose rumen-protected methionine (0.9 g·kg-1 of dry matter intake) during the last 28 
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METHIONINE SUPPLY DURING LATE-GESTATION TRIGGERS OFFSPRING SEX-
SPECIFIC DIVERGENT CHANGES IN METABOLIC AND EPIGENETIC 
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The placenta plays a key role in the maternal-fetal relationship, maintaining fetal 
homeostasis through the regulation of nutrient transfer (Myatt, 2006; Sibley et al., 2010). Both the 
development and function of the placenta are subject to dynamic regulation by nutrient status 
(Cross and Mickelson, 2006). Furthermore, the placenta has long been considered an asexual 
organ, but growing evidence indicates that maternal diet triggers sex-specific placental responses 
(Gabory et al., 2012; Tarrade et al., 2015). Despite its importance in the maternal-fetal relationship, 
the effects of maternal nutritional status on metabolism of the placenta and its function in nutrition-
adaptive processes in large mammalian species such as cattle are still poorly understood.  
Epigenetic marks serve as memory of exposure to the environment, potentially affecting  
fetal and placental programming (Heijmans et al., 2009). These type of modifications refer to 
heritable changes in gene expression that are not mediated by alterations in the DNA sequence 
(Jaenisch and Bird, 2003). Epigenetic mechanisms include DNA methylation, histone 
modification and microRNA, with the former being the most-studied  (He et al., 2011). The DNA 
methyltransferase (DNMT) family is composed of 5 members: DNMT1, DNMT2, DNMT3A, 
DNMT3B, and DNMT3L (Jin et al., 2011). DNMT1, DNMT3A, and DNMT3B catalyze the 
addition of methylation marks to genomic DNA, while DNMT2 and DNMT3L do not engage in 
catalytic DNMT activity (Lyko, 2017). Although there are exceptions, DNA methylation usually 
downregulates gene expression, whereas hypomethylation often increases transcription (Futscher 
et al., 2002). 
Evidence suggests that cellular metabolites and plane of nutrition alter epigenetic marks. 
In non-ruminants, the maternal nutritional status influences the methylation profile of the fetal 




choline (Waterland, 2003; Zeisel, 2012). Studies further indicate that epigenetic regulation of fetal 
genes represents an important mechanism mediating fetal programming and raises the possibility 
that genes expressed in the placenta, an organ directly exposed to maternal blood, are modified 
epigenetically by perturbations in the maternal compartment (Jansson and Powell, 2007). For 
example, high-fat diets trigger sex-specific gene expression in mouse placenta (Gallou-Kabani et 
al., 2010; Gabory et al., 2012). 
In the present study, a subset of animals from the previously published work (Batistel et 
al., 2017a; Batistel et al., 2017c; Batistel et al., 2018) were used to address the hypothesis that 
increasing the maternal methionine supply during late-pregnancy triggers offspring sex-specific 
metabolic and epigenetic signatures in bovine placenta. Thus, the main aim was to determine the 
effects of rumen-protected methionine supplementation during the last 28 days of pregnancy on 
metabolites, gene expression, and activity of enzymes involved in the TCA cycle, one-carbon 
metabolism and DNA methylation in bovine placenta from cows carrying male or female 
offspring. 
METHODS 
Animals, experimental design and treatments  
The Institutional Animal Care and Use Committee at University of Illinois (Urbana; 
protocol # 14270) approved all the experimental procedures. Details of the experimental design 
have been reported previously (Batistel et al., 2017b). Briefly, 80 multiparous Holstein cows were 
used in a randomized, complete block design experiment with 30 cows per treatment. Cows were 
blocked by the expected day of parturition, and the blocks were balanced by parity, previous 305-
days milk yield, and body condition score. The body condition score used to block cows was 




(Wildman et al., 1982). Cows were fed the experimental treatments consisting of a control 
(Control; n = 40; 1.47 Mcal·kg-1 of dry matter) diet with no added methionine or the control diet 
plus ethyl-cellulose rumen-protected methionine (Methionine; Mepron®, Evonik Nutrition & Care 
GmbH, Germany; n = 40) during the last 28 days of pregnancy. The methionine product was 
supplied (top-dressed) at a rate of 0.9 g·kg-1 of dry matter on the total mixed diet. This supply of 
methionine was based on recent experiments demonstrating a benefit of achieving a 
Lysine:Methionine ratio in metabolizable protein reaching the small intestine close to 2.8:1 in 
terms of production performance and health (Osorio et al., 2013; Zhou et al., 2016b). The 
Lysine:Methionine ratio in the Control diet was to 3.7:1. Mepron® is a commercial rumen-
protected source of DL-methionine which resists ruminal degradation through an ethyl-cellulose 
film coating. Pellets measure 1.8 × 3 mm and contain 85% DL-methionine. Mepron® contains an 
equimolar mixture of the D- and L-isomers and a minimum of 75 ± 3% of the ingested D-
methionine is transformed into L-methionine by the dairy cow (Lapierre et al., 2012). The 
intestinal digestibility coefficient and ruminal bypass value of Mepron is 90% (Schwab, 1995) and 
80% (Overton et al., 1996); therefore, per 10 g of Mepron, the cows received 6.1 g methionine 
available for absorption. During the preliminary period (from -45 to -29 days relative to the 
expected parturition day) all cows received the same diet containing 1.33 Mcal·kg-1 of dry matter 
with no added methionine. Treatment diets were mixed daily in a tumble-mixer and fed once daily 
(1300 h). The ingredient and chemical composition of the diets were reported previously (Batistel 
et al., 2017a). Diets were formulated to meet cow’s predicted requirements for energy, protein, 
minerals and vitamins according to the National Research Council (NRC) (NRC, 2001). Individual 




Calves were weighed soon after parturition (~30 min) and before colostrum consumption. 
They received 3.8 L of first milking colostrum within 6 h after birth, if colostrum intake had not 
reached the 3.8 L required; calves were force-fed via esophageal tube. Calves were fed twice daily 
(0700 and 1800 h) with a milk replacer (Advance Excelerate, Milk Specialities, Carpentersville, 
IL; 28.5% CP, 15% fat) until 35 days of age. At this point they were then switched to once a day 
feeding at 0700 h until weaning (42 days of age). The amount of milk replacer received by the 
calves was age dependent as follow: from 1 to 10 days of age, 4.54 kg per day; from 11 to 20 days 
of age, 5.90 kg per day; from 21 to 35 days of age, 7.26 kg per day; from 36 to 42 days of age, 
3.63 kg per day. Calves had ad libitum access to a starter grain mix (19.9% crude protein, 13.5% 
neutral detergent fiber) at 0800 h. Calves were housed in individual outdoor hutches bedded with 
straw until 56 days of age and later they were kept in an outdoor pen in group. Daily intake of 
starter were measured until 42 days of age and growth performance including body weight, hip 
height, wither height and hip width were recorded once a week until 63 days of age (9 weeks). 
Blood collection 
Blood samples from cows were collected from the coccygeal vessel before the morning 
meal at day -7 relative to expected parturition. Samples were collected into evacuated tubes (BD 
Vacutainer; Becton, Dickinson and Company) containing lithium heparin. After collection, 
samples were placed on ice until centrifugation (~40 min). Plasma was obtained by centrifugation 
at 2000 × g for 30min at 4 °C. Aliquots of plasma were frozen (-80 °C) until further analysis. 
Placentome collection 
Placentome samples were collected at term and stored as previously described (Batistel et 
al., 2017a). A subset of samples was chosen based on number of days that cows received the 




offspring. Samples were then organized according to diet and offspring sex as follows: Male CTR 
(n = 7), Male MET (n = 7), Female CTR (n = 8), and Female MET (n = 8). 
Laboratory analyses 
Biomarkers of energy balance and amino acids (AA). Glucose (catalog no. 0018250840) and urea 
(catalog no. 0018255440) were analyzed using the IL Test purchased from Instrumentation 
Laboratory Spa (Werfen Co., Milan, Italy) in the ILAB 600 clinical autoanalyzer (Instrumentation 
Laboratory, Lexington, MA). Fatty acids and β-hydroxybutyrate were measured using kits from 
Wako Chemicals (Richmond, VA) and Randox Laboratories Ltd. (Crumlin, United Kingdom), 
respectively, following the procedures described previously (Bionaz et al., 2007; Trevisi et al., 
2012). Plasma AA concentration analysis was performed according to established protocols 
(AOAC, 1995). 
RNA isolation, cDNA Synthesis and Quantitative PCR. Total RNA was isolated from 100 mg of 
placentome tissue using the miRNeasy kit (Qiagen) following the manufacturer’s protocols. 
Samples were treated on-column with DNaseI (Qiagen); quantification was assessed using the 
NanoDrop ND-1000 (NanoDrop Technologies), and RNA quality was measured using an Agilent 
2100 Bioanalyzer (Agilent). All samples had an RNA integrity number factor greater than 7. The 
RT-PCR was performed as described previously (Osorio et al., 2014a). Primer information and 
RT-PCR performance are included in the Online Supporting Material. 
Metabolomics. One-hundred mg of frozen tissue was extracted by the two-step protocol described 
by Wu et al. (Wu et al., 2008). Targeted metabolomics (LC-MS) was performed to quantify 32 
metabolites related to the TCA cycle, one carbon metabolism and the transsulfuration pathway. 




Software Analyst 1.6.2 was used for data acquisition and analysis. The 1200 series HPLC system 
(Agilent Technologies, Santa Clara, CA) includes a degasser, an autosampler, and a binary pump. 
The LC separation was performed on a Phenomenex C18 (2) column (4.6 × 150 mm, 5 μm. 
Torrance, CA) with mobile phase A (10 mM ammonia formate) and mobile phase B (methanol). 
The flow rate was 0.4 mL/min. The linear gradient was as follows: 0-1 min, 95% A; 8 min, 50% 
A; 15-18 min, 0% A; 18.1-26 min, 95% A. The autosampler was set at 10 °C. The injection volume 
was 10 μL. Mass spectra were acquired under both positive (ion spray voltage was +5500 V) and 
negative (ion spray voltage was -4500 V) electrospray ionization (ESI). The source temperature 
was 500 °C. The curtain gas, ion source gas 1, and ion source gas 2 were 35, 65, and 55, 
respectively. Multiple reaction monitoring was used for quantitation. Before statistical analysis, 
the area under the curve (AUC) was normalized by the protein concentration of the samples. 
Enzyme activity assay. Betaine homocysteine methyltransferase (BHMT) and 5-
methyltetrahydrofolatehomocysteine methyltransferase (MTR) activity was measured as 
described by Garrow (Garrow, 1996) and Banerjee et al. (Banerjee et al., 1997), respectively. 
Cystathionine β-synthase (CBS) activity was determined on the basis of Lambert et al. (Lambert 
et al., 2002), with the separation of 14C-cystathionine from 14C-Ser according to Taoka et al. (Taoka 
et al., 1998). 
DNA isolation and Global DNA methylation. The DNA was isolated from 50 mg of placentome 
tissue using the Blood and Tissue DNeasy Kit (Qiagen). The methylation of the genomic DNA 
was detected using the Methylamp global DNA methylation quantification ultra-kit (Epigentek) 
according to the manufacturer’s instructions. In this assay, genomic DNA is immobilized in strip 
wells specifically coated with a DNA-affinity substance. The methylated fraction of DNA can be 




amount of methylated DNA is proportional to the optical density (OD). Absorbance of positive 
(methylated) and negative (unmethylated) control DNA were measured by a microplate reader 
(Biotek). The amount of DNA methylation was calculated using the following formula: 
𝑀𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑖𝑜𝑛 % =
(sample OD − negative control OD)/Xⁱ 
(positivecontrol OD − negative control OD) × 10 
× 100 
The amount of the positive control was 10 ng, and sample DNA was adjusted to 100 ng. Xⁱ 
is the GC content of the species DNA; in the present study it was 41.7% (Bovine Genome et al., 
2009). 
Statistical analysis  
The complete data set of cows (Male CTR: n =15; Male MET: n = 15; Female CTR: n =15; 
Female MET: n = 15) was used to analyze animal performance. In doing so, we ensured 
appropriate biological replication to detect small changes in these phenotypes, which inherently 
have higher variability. The data were analyzed separately for males and females. All data were 
analyzed using the MIXED procedure of SAS 9.4 (SAS Institute) according to the following 
model: 
Yij = μ + bi + Mj + eij, 
where Yij = dependent, continuous variable, μ = overall mean, bi = random effect of block (i = 1 to 
7), Mj = fixed effect of treatment (j = control versus methionine), and eijk = residual error. For the 
calves measurements until 9 weeks of age (body weight, hip height, wither height, hip width and 
starter intake) time and the interaction time × treatment were included as fixed effect in the model.  
For gene expression, the data were log-2 transformed before analysis and log-back transformed 




homogeneity of variances with plots of residuals versus predicted values. Data are presented as 
least-square means with pooled SEMs. Significance was declared at P ≤ 0.05 and tendencies at P 
≤ 0.10. 
RESULTS 
Animal performance and plasma biomarkers 
Compared with cows carrying Male CTR, the cows carrying Male MET had greater dry 
matter intake (P = 0.03) and the plasma biomarkers of energy balance were not affected by 
methionine supply (Table 5.1). Cows carrying Male MET had greater plasma concentrations of 
methionine (P = 0.04) and tented to have greater concentrations of alanine (P = 0.10) than cows 
carrying Male CTR. Plasma concentrations of histidine, isoleucine, leucine, lysine, threonine, 
valine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, proline, 
serine, and tyrosine were not affected by treatments. Compared with cows carrying Male CTR, the 
cows carrying Male MET delivered heavier calves (P = 0.01), and those calves had greater hip 
height (P = 0.03) and wither height (P = 0.03) until 9 weeks of age. Body weight, hip width, body 
length, and starter intake until 9 weeks of age were not affected by the maternal treatments. 
Similar responses were observed in female placenta, with cows carrying Female MET 
having greater (P = 0.02) dry matter intake than cows carrying Female CTR (Table 5.2). None of 
the plasma biomarkers were affected by methionine supply. Compared with Female CTR, 
methionine supply enhanced the plasma concentrations of methionine (P = 0.01) and alanine (P = 
0.05). Methionine supply did not affect the plasma concentrations of histidine, isoleucine, leucine, 
lysine, threonine, valine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, 
glycine, proline, serine, and tyrosine. Although maternal methionine supply to cows carrying 




(P = 0.03), hip height (P = 0.02) and wither height (P = 0.04) until 9 weeks of age. Starter intake 
until 9 weeks of age was not affected by the maternal diet. 
Metabolomics 
Compared with the placenta from Male CTR, that from Male MET had greater 
concentrations of two metabolites related to the TCA cycle (isocitrate acid, P = 0.04; and 
NAD/NADH, P = 0.05) and three related to the transsulfuration pathway (cysteinesulfinic acid, P 
= 0.02; glutathione, P = 0.04; and vitamin B12, P = 0.03; Table 5.3). None of the metabolites 
involved in the one-carbon metabolism in the male placenta samples was affected by methionine 
supply. 
The Female MET placenta had greater concentrations of metabolites related to one-carbon 
metabolism [methionine, P = 0.03; and S-adenosyl-methionine (SAM), P = 0.05] than the Female 
CTR placenta (Table 5.4). None of the metabolites related to the TCA cycle or transsulfuration 
pathway in the female placenta samples were affected by methionine supply. 
mRNA abundance 
Compared with Male CTR, the placenta from Male MET had greater mRNA abundance 
of CS (P = 0.05), ACO2 (P = 0.04), and MDH (P = 0.02), which are involved in the TCA cycle 
(Table 5.5). Furthermore, Male MET placenta had greater mRNA abundance of AHCY (P = 0.03; 
one-carbon metabolism) and GSR (P = 0.03; transsulfuration pathway), and tented to have 
greater mRNA abundance of CBS (P = 0.08; transsulfuration pathway) compared with Male 
CTR placenta. The mRNA abundance of the DNMTs (DNMT1, DNMT3A, and DNMT3B) in the 
male placenta was not affected by methionine supply (Figure 5.1). 
Compared with Female CTR, the placenta from Female MET had greater mRNA 




transsulfuration pathway), GSR (P = 0.01) and GPX1 (P = 0.05; transsulfuration pathway) (Table 
5.6). Compared with Female CTR, greater supply of methionine led to greater mRNA abundance 
of de novo DNMT (DNMT3A, P = 0.01; and DNMT3B, P = 0.06), while DNMT1 was not affected 
(Figure 5.1). 
Enzyme activity 
Compared with Male CTR placenta, greater supply of methionine led to greater MTR (P = 
0.03) activity in male placenta. Activity of BHMT and CBS in the male placenta was not affected 
by methionine supply (Figure 5.2). Activity of BHMT, MTR and CBS was the same in Female 
CTR and Female MET placenta (Figure 5.2). 
Global DNA methylation 
Global DNA methylation did not differ between Male CTR and Male MET placenta, while 
a tendency of lower (P = 0.06) global DNA methylation was observed in the placenta from Female 
MET compared with Female CTR (Figure 5.3). 
DISCUSSION 
Proper placental metabolism is required to ensure that dairy cattle can provide the required 
nutrients to support the marked fetal growth occurring in the final trimester of gestation (NRC, 
2001). Because of their role in milk production and replacement of older cows, female offspring 
are desired by farmers. In non-ruminant animals, the maternal diet can elicit a non-genetic 
inheritable effect that is associated with sexual dimorphism (Tarrade et al., 2015; Lecoutre et al., 
2016), and the placenta seems to be a key programming mediator (Gabory et al., 2012; Tarrade et 
al., 2015). To our knowledge, the potential effects of maternal diet on metabolism and epigenetic 




in cattle.  Thus, our main aim was to perform an initial evaluation of sex-specific functional 
differences based on both metabolic and epigenetic analysis in the bovine placenta and calf 
performance from cows receiving an enhanced supply of methionine. 
Animal performance and TCA cycle 
The tremendous metabolic activity of the bovine placenta can account for 60-70% of the 
glucose taken up by the utero-placental tissues (Reynolds et al., 1986). Compared with the fetus, 
glucose consumption by the placenta increases 10-fold during late gestation (Fowden, 1997). 
Although glucose is the principal source of energy for the bovine placenta, other substrates such 
as lactate (from glycolysis), fatty acids, amino acids, and ketone bodies (acetate, acetoacetate and 
β-hydroxybutyrate) originated from ruminal fermentation can be used in small portions. Except 
for isocitrate dehydrogenase, which increased the activity as parturition approached, in ovine 
placenta the activity of other enzymes involved in the TCA cycle did not change during the last 3 
months of pregnancy (Edwards et al., 1977). In the present study, the greater dry matter intake, 
plasma concentration of methionine and alanine, concentrations of TCA intermediates, mRNA 
expression of TCA enzymes, and NAD/NADH indicated greater energy production through the 
TCA cycle in placenta from cows carrying male calves and receiving enhanced methionine supply. 
These results seem to be associated with newborn birth weight, as demonstrated by the positive 
correlation between placenta size and calf body weight at birth (Zhang et al., 1999). The fact that 
the greater calf birth body weight detected in response to methionine supply was associated with 
male than female supports previous data. 
One-carbon metabolism and transsulfuration pathway 
One-carbon metabolism encompasses the folate and methionine cycles, and the 




homocysteine (Locasale, 2013). One-carbon metabolism functions as a metabolic integrator of 
nutrient status and supports multiple physiologic processes including biosynthesis of nucleotides, 
amino acid homeostasis (methionine, glycine and serine), epigenetic maintenance, and antioxidant 
defense (taurine and glutathione) (Locasale, 2013; Ducker and Rabinowitz, 2017). 
The antioxidant capacity of glutathione and taurine are especially important during 
pregnancy because the placenta is a site of active oxidative metabolism, continuously generating 
reactive oxygen species and needs to be buffered to avoid oxidative stress (Myatt and Cui, 2004). 
In human placenta, oxidative stress causes trophoblast apoptosis, placental dysfunction (Myatt and 
Cui, 2004), and immune disturbances (Wu et al., 2016). Thus, data from placenta of cows carrying 
males and receiving enhanced supply of methionine indicated a more favorable intersection of the 
pathways to re-methylate homocysteine into methionine, and utilize homocysteine for glutathione 
synthesis via transsulfuration. These results are noteworthy because in hepatocytes, homocysteine 
generated from methionine is substrate for re-methylation and transsulfuration, with SAM playing 
a regulatory role on the utilization of homocysteine (Finkelstein, 2007). When methionine 
concentration is low, homocysteine is used to regenerate methionine (Blom and Smulders, 2011) 
by the MTR enzyme, which uses vitamin B12 as a co-factor (Banerjee and Matthews, 1990). In 
contrast, when methionine is in excess, the high levels of SAM generated activate CBS favoring 
the transsulfuration pathway that produces cysteine which can be converted into taurine and 
glutathione (Blom and Smulders, 2011). 
Because male calves born to cows receiving greater methionine supply had greater body 
weight at birth and the placental levels of methionine and SAM were not altered, we speculate that 
substantial amounts of methionine were used to support fetal growth and homocysteine was used 




methionine and glutathione concentrations in the placenta. This is supported by the higher rate of 
re-methylation observed in late-gestation placenta in humans (Dasarathy et al., 2010), and 
reinforce the greater methionine requirement for fetal growth during late pregnancy. 
Even in the presence of physiological concentrations of cysteine, at least half of the 
cysteine required for glutathione synthesis is provided by transsulfuration (Mosharov et al., 2000). 
In contrast to placenta from cows carrying male calves, the absence of differences in birth body 
weight and the higher levels of methionine and SAM in placenta from cows carrying female calves 
and receiving greater methionine supply indicated enhanced availability of methionine, likely 
causing the upregulation of the transsulfuration pathway. 
DNA methylation 
DNA methylation is an epigenetic mechanism which establishes and preserves tissue-
specific patterns of gene expression (Moore et al., 2013). Because the methyl groups transferred 
into DNA are ultimately derived from methionine, dietary intake of methionine might be expected 
to alter DNA methylation (Waterland, 2006). In human placenta, higher intake of choline led to 
greater promoter methylation in the corticotrophin releasing hormone and glucocorticoid receptor 
genes (Jiang et al., 2012). Recent studies also revealed effects of methyl donor supply on the 
offspring in a sex-dependent manner. Maloney et al. (Maloney et al., 2011) observed that maternal 
supply of choline and methionine during the first 5 days of gestation changed glucose metabolism 
only in male offspring. The fact that methionine supply altered the epigenetics signatures only in 
placenta from female offspring compared with male offspring agrees with those findings. The 
lower global DNA methylation and the greater abundance of DNMT3A and DNMT3B in placenta 
from cows carrying female calves and receiving a greater supply of methionine underscored the 




these seemingly-opposite results is that the extra energy available to placenta due to greater dry 
matter intake in cows carrying female calves and fed methionine stimulated active DNA 
methylation (Bochtler et al., 2017) which was followed by de novo methylation (DNMT3A and 
DNMT3B). The DNA methylation changes observed may be the mechanism behind the 
differences observed in calf performance until 9 weeks of age. 
In summary, the present findings indicate that maternal methionine supply during late 
gestation could alter placental metabolism as well as DNA methylation in an offspring sex-
dependent manner. Additional research in this area to clarify the potential effects of methionine 





TABLE 5.1 Cow dry matter intake, plasma biomarkers of energy balance and amino acids prior 
to parturition, and calf performance in animals carrying male offspring. Cows were fed a control 
diet or the control plus rumen-protected methionine (0.9 g/kg dry matter intake) during the last 28 




SEM  P value 
Control Methionine 
Cows     
 Dry matter intake, kg/d 14.8 15.4 0.18 0.03 
 Plasma biomarkers, mmol/L     
  β-hydroxybutyrate 0.63 0.57 0.13 0.59 
  Glucose 4.51 4.53 0.09 0.65 
  Fatty acids 0.18 0.19 0.07 0.87 
  Urea 6.51 6.80 0.31 0.72 
 Amino acids, µM     
  Histidine 39.1 41.7 3.12 0.34 
  Isoleucine 103 116 10.2 0.29 
  Leucine 146 151 13.5 0.45 
  Lysine 55.3 69.8 7.06 0.34 
  Methionine 12.6 16.7 1.91 0.04 
  Phenylalanine 39.3 38.3 2.17 0.58 
  Threonine 55.2 67.5 6.65 0.16 
  Valine 214 252 21.3 0.38 
  Alanine 165 183 9.02 0.10 
  Arginine 57.4 59.4 5.04 0.77 
  Asparagine 25.6 25.9 3.53 0.65 
  Aspartic acid 9.65 9.54 1.62 0.62 
  Cysteine 0.53 0.54 0.37 0.84 
  Glutamic acid 48.9 49.1 4.15 0.73 
  Glutamine 214 219 14.3 0.48 
  Glycine 164 163 32.6 0.58 
  Proline 58.4 65.4 5.98 0.56 
  Serine 44.3 48.6 5.32 0.47 
  Tyrosine 37.5 41.6 3.54 0.35 
Calves      
 Body weight at birth, kg 43.9 46.1 1.29 0.01 
 Measurements until 9 weeks of age1 
  Body weight, kg 62.7 65.3 1.27 0.16 
  Hip height, cm 87.2 89.1 0.59 0.03 
  Hip width, cm 20.6 21.0 0.20 0.21 
  Wither height, cm 82.9 84.8 0.59 0.03 
  Body length, cm 128 129 0.88 0.64 
 Starter intake, kg 0.8 0.84 0.04 0.55 
1P values for time and time × treatment, respectively: body weight = <0.01 and 0.92; hip height = <0.01 and 0.99; hip width = 





TABLE 5.2 Cow dry matter intake, plasma biomarkers of energy balance and amino acids prior 
to parturition, and calf performance in animals carrying female offspring. Cows were fed a control 
diet or the control plus rumen-protected methionine (0.9 g/kg dry matter intake) during the last 28 




SEM  P value 
Control Methionine 
Cows     
 Dry matter intake, kg/d 14.6 15.9 0.19 0.02 
 Plasma biomarkers, mmol/L     
  β-hydroxybutyrate 0.65 0.58 0.14 0.53 
  Glucose 4.53 4.61 0.08 0.58 
  Fatty acids 0.19 0.18 0.07 0.91 
  Urea 6.72 6.75 0.31 0.93 
 Amino acids     
  Histidine 37.2 44.2 3.78 0.26 
  Isoleucine 107 117 9.87 0.37 
  Leucine 141 146 11.5 0.87 
  Lysine 58.1 63.1 6.87 0.19 
  Methionine 9.76 14.1 1.98 0.01 
  Phenylalanine 36.3 39.0 2.34 0.58 
  Threonine 60.8 62.7 6.07 0.87 
  Valine 213 217 25.8 0.91 
  Alanine 142 163 10.3 0.05 
  Arginine 59.3 61.8 5.65 0.87 
  Asparagine 24.3 23.8 3.95 0.76 
  Aspartic acid 10.5 10.1 1.65 0.81 
  Cysteine 0.50 0.53 0.61 0.87 
  Glutamic acid 47.7 49.6 5.06 0.78 
  Glutamine 225 232 14.5 0.36 
  Glycine 145 163 25.8 0.42 
  Proline 55.4 52.4 6.01 0.76 
  Serine 52.2 55.8 5.07 0.56 
  Tyrosine 40.2 37.5 4.08 0.36 
Calves     
 Calf birth weight, kg 41.0 41.4 1.02 0.71 
 Measurements until 9 weeks of age1 
  Body weight, kg 59.1 62.8 1.12 0.03 
  Hip height, cm 86.5 88.4 0.56 0.02 
  Hip width, cm 20.0 20.2 0.21 0.49 
  Wither height, cm 82.5 84.1 0.53 0.04 
  Body length, cm 124.3 126.5 1.09 0.15 
 Starter intake, kg 0.77 0.86 0.05 0.18 
1P values for time and time × treatment, respectively: body weight = <0.01 and 0.11; hip height = <0.01 and 0.72; hip width = 





TABLE 5.3 Relative metabolite concentrations (area under the curve, AUC) in placentomes from 
cows carrying male calves and fed a control diet or the control plus rumen-protected methionine 
(0.9 g/kg dry matter intake) during the last 28 d prior to parturition. Values are means ± pooled 
SEMs, n = 7 samples per treatment. 
Metabolite 
Cow treatment 
SEM  P value 
Control Methionine 
TCA cycle, AUC     
  Acetyl CoA ND1 ND - - 
  Isocitrate acid 114 186 23 0.04 
  α-ketoglutarate 2707 2977 280 0.55 
  Succinyl CoA ND ND - - 
  Malic acid 317729 347824 36309 0.36 
  NAD/NADH 24048 39816 5256 0.05 
  FAD/FADH 9507 10263 2323 0.84 
  UDP 2394 2909 401 0.42 
One-carbon metabolism, AUC     
  Methionine 645970 663383 92797 0.86 
  S-5'-adenosyl-methionine 123433 159410 31122 0.46 
  S-5'-adenosyl-homocysteine 
 
18077 20805 2149 0.43 
  N-methylglycine 2698 2549 193 0.59 
  Glycine 31349 31587 2432 0.95 
  Homocysteine 90.8 1727 1177 0.35 
  Adenosine 5600 4877 1371 0.74 
  5-methyltetradydrofolic acid 9279 10047 1570 0.75 
  Tetrahydrofolic acid ND ND - - 
  Folic acid 97 89 23 0.83 
  N,N-dimethylglycine 156932 172463 15627 0.49 
  Betaine 32469 32553 2650 0.98 
  Choline 355246 390905 31539 0.28 
Transsulfuration pathway, AUC     
  Homocysteine 1727 1930 86 0.15 
  Serine 217769 225319 24301 0.83 
  Cystathionine 52891 70976 4533 0.34 
  Cysteine 13058 15023 2666 0.61 
  Cysteinesulfinic acid 214 464 71 0.02 
  Hypotaurine 15457 14441 2077 0.73 
  Taurine 30653 31337 2745 0.87 
  Glutathione 190256 383132 61835 0.04 
  Vitamin B12 35 66 9 0.03 
  Vitamin B6 ND ND - - 




TABLE 5.4 Relative metabolite concentrations (area under the curve, AUC) in placentomes from 
cows carrying female calves and fed a control diet or the control plus rumen-protected methionine 
(0.9 g/kg dry matter intake) during the last 28 d prior to parturition. Values are means ± pooled 
SEMs, n = 8 samples per treatment. 
Metabolite 
Cow treatment 
SEM  P value 
Control Methionine 
TCA cycle, AUC     
  Acetyl CoA ND1 ND - - 
  Isocitrate acid 154 135 21 0.25 
  α-ketoglutarate 2846 2838 291 0.61 
  Succinyl CoA ND ND - - 
  Malic acid 317824 302806 35784 0.41 
  NAD/NADH 33212 32977 5256 0.35 
  FAD/FADH 9408 10362 1985 0.65 
  UDP 2606 2696 541 0.65 
One-carbon metabolism, AUC     
  Methionine 626542 710978 35421 0.03 
  S-5'-adenosyl-methionine 123983 188860 29812 0.05 
  S-5'-adenosyl-homocysteine 
 
15384 18498 2058 0.21 
  N-methylglycine 2683 2565 210 049 
  Glycine 32012 31925 2358 0.89 
  Homocysteine 91 86 8 0.85 
  Adenosine 5977 4598 1247 0.24 
  5-methyltetradydrofolic acid 9384 9542 1485 0.85 
  Tetrahydrofolic acid ND ND - - 
  Folic acid 76.2 108.9 18 0.53 
  N,N-dimethylglycine 160115 169280 9854 0.65 
  Betaine 30979 35242 2051 0.18 
  Choline 363913 382239 32364 0.35 
Transsulfuration pathway, AUC     
  Homocysteine 1291 1186 286 0.85 
  Serine 216739 226349 22124 0.75 
  Cystathionine 32891 31164 5124 0.64 
  Cysteine 13442 14068 2516 0.72 
  Cysteinesulfinic acid 331 294 75 0.58 
  Hypotaurine 13834 15064 2145 0.54 
  Taurine 31716 30274 2854 0.81 
  Glutathione 206256 267010 65244 0.36 
  Vitamin B12 26 24 6 0.35 
  Vitamin B6 ND ND - - 




TABLE 5.5 mRNA abundance in placentomes from cows carrying male calves and fed a control 
diet or the control plus rumen-protected methionine (0.9 g/kg dry matter intake) during the last 28 
d prior to parturition. Values are means ± pooled SEMs, n = 7 samples per treatment. 
Gene 
Cow treatment 
SEM  P value 
Control Methionine 
TCA cycle, mRNA abundance 
  CS 0.95 1.08 0.07 0.05 
  ACO2 0.85 0.99 0.07 0.04 
  IDH1 1.00 0.97 0.05 0.54 
  OGDH 1.11 1.13 0.06 0.44 
  SUCLA2 0.59 0.64 0.07 0.68 
  SDHA 0.86 0.83 0.05 0.45 
  FH 0.96 0.98 0.07 0.58 
  MDH1 0.92 1.08 0.05 0.02 
One-carbon metabolism, mRNA abundance 
  BHMT 0.89 0.96 0.05 0.28 
  MTR 1.11 1.10 0.08 0.45 
  MAT1A 0.68 0.71 0.07 0.48 
  GNMT 0.79 0.75 0.10 0.85 
  AHCY 0.96 1.15 0.06 0.03 
Transsulfuration pathway, mRNA abundance 
  CBS 0.79 0.94 0.08 0.05 
  CTH 0.66 0.79 0.08 0.15 
  CDO 1.02 0.96 0.13 0.45 
  GSR 1.02 1.18 0.06 0.03 





TABLE 5.6 mRNA abundance in placentome from cows carrying female calves and fed a control 
diet or the control plus rumen-protected methionine (0.9 g/kg dry matter intake) during the last 28 
d prior to parturition. Values are means ± pooled SEMs, n = 8 samples per treatment. 
Gene 
Cow treatment 
SEM  P value 
Control Methionine 
TCA cycle, mRNA abundance 
  CS 0.97 1.01 0.08 0.45 
  ACO2 0.95 0.92 0.06 0.85 
  IDH1 0.80 0.78 0.06 0.74 
  OGDH 0.98 1.03 0.08 0.78 
  SUCLA2 0.64 0.65 0.07 0.59 
  SDHA 0.91 0.87 0.06 0.45 
  FH 0.75 0.78 0.08 0.58 
  MDH1 0.72 0.76 0.07 0.76 
One-carbon metabolism, mRNA abundance 
  BHMT 1.12 1.17 0.07 0.28 
  MTR 0.99 0.94 0.09 0.47 
  MAT1A 0.88 1.09 0.06 <0.01 
  GNMT 0.79 0.75 0.10 0.85 
  AHCY 0.87 0.94 0.07 0.16 
Transsulfuration pathway, mRNA abundance 
  CBS 0.81 0.89 0.07 0.25 
  CTH 0.73 0.84 0.06 0.10 
  CDO 0.86 0.94 0.08 0.24 
  GSR 0.94 1.08 0.05 0.01 



































































Treatment P = 0.55 
Treatment P = 0.95





























































































Treatment P = 0.08



































Figure 5.1 mRNA abundance of DNA methyltransferase placentomes from cows carrying male 
(A-C) or female (D-F) calves and fed a control diet or the control plus rumen-protected methionine 
(0.9 g/kg dry matter intake) during the last 28 d prior to parturition. Values are means ± pooled 




































































Treatment P = 0.03 
Treatment P = 0.38



































































































Treatment P = 0.76
Treatment P = 0.57




































Figure 5.2 Enzyme activities of betaine-homocysteine S-methyltransferase (BHMT), methionine 
synthase (MTR), and cystathionine-beta-synthase (CBS) in placentomes from cows carrying male 
(A-C) or female (D-F) calves and fed a control diet or the control plus rumen-protected methionine 
(0.9 g/kg dry matter intake) during the last 28 d prior to parturition. Values are means ± pooled 




























































Figure 5.3 Global DNA methylation in placentomes from cows carrying male (A) or female (B) 
calves and fed a control diet or the control plus rumen-protected methionine (0.9 g/kg dry matter 
intake) during the last 28 d prior to parturition. Values are means ± pooled SEMs; n = 7 
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